Gefitinib (ZD1839)

For research use only. Not for use in humans.

目录号：S1025

Molecular Weight(MW): 446.90

Gefitinib (ZD1839)是一种EGFR抑制剂，作用于NR6wtEGFR和NR6W细胞中的Tyr1173，Tyr992，Tyr1173和Tyr992，IC50 分别为37 nM，37nM，26 nM和57 nM。

规格

价格

库存

购买数量

10mM (1mL in DMSO)	RMB 1574.78	现货
100mg	RMB 1227.69	现货
250mg	RMB 2205.98	现货
大包装	有超大折扣

大剂量询单有大折扣！

今日订购，明日送达，全国免运费！

全国免费电话：400-668-6834 | Email：info@selleck.cn

客户使用Selleck生产的Gefitinib (ZD1839)发表文献287篇：

Cancer Discov, 2019, 9(7):926-943

PubMed: 31092401 ( click the link to review the publication )

Cell Stem Cell, 2019, 25(1):69-86

PubMed: 31080136 ( click the link to review the publication )

Cell, 2018, 172(1-2):373-386

PubMed: 29224780 ( click the link to review the publication )

Nat Med, 2018, 24(4):512-517

PubMed: 29505033 ( click the link to review the publication )

Nat Methods, 2018, 15(8):631-639

PubMed: 30038414 ( click the link to review the publication )

Cancer Cell, 2018, 34(3):427-438

PubMed: 30205045 ( click the link to review the publication )

Nature, 2017, 547(7664):453-457

PubMed: 28678785 ( click the link to review the publication )

Cell Stem Cell, 2017, 20(2):233-246

PubMed: 27989769 ( click the link to review the publication )

Nature, 2016, 534(7609):647-51

PubMed: 27338794 ( click the link to review the publication )

Nat Med, 2016, 22(3):262-9

PubMed: 26828195 ( click the link to review the publication )

Cancer Discov, 2015, 5(7):713-22

PubMed: 25934077 ( click the link to review the publication )

Cancer Discov, 2015, 5(9):960-971

PubMed: 26036643 ( click the link to review the publication )

Nature, 2014, 508(7494):118-22

PubMed: 24670642 ( click the link to review the publication )

Nat Med, 2013, 19(11):1469-1472

PubMed: 24162815 ( click the link to review the publication )

Nature, 2012, 483(7387):100-3

PubMed: 22281684 ( click the link to review the publication )

Cell, 2012, 151(5):937-50

PubMed: 23178117 ( click the link to review the publication )

Cancer Discov, 2012, 2(10):934-47

PubMed: 22961667 ( click the link to review the publication )

Cancer Discov, 2011, 1(7):608-25

PubMed: 22586683 ( click the link to review the publication )

Nat Cell Biol, 2019, 21(6):778-790

PubMed: 31160710 ( click the link to review the publication )

Nat Microbiol, 2019, 4(2):216-225

PubMed: 30420785 ( click the link to review the publication )

Mol Cell, 2019, 73(1):166-182

PubMed: 30609389 ( click the link to review the publication )

Hepatology, 2019, 10.1002/hep.30780

PubMed: 31127639 ( click the link to review the publication )

Nat Commun, 2019, 10(1):2701

PubMed: 31221965 ( click the link to review the publication )

Nano Lett, 2019, 19(10):7526-7533

PubMed: 31487192 ( click the link to review the publication )
Nat Commun, 2019, 10(1):2919

PubMed: 31266962 ( click the link to review the publication )

Autophagy, 2019, 10.1080/15548627.2019.1660545

PubMed: 31462148 ( click the link to review the publication )

Autophagy, 2019, 10.1080/15548627.2019.1660545

PubMed: 31462148 ( click the link to review the publication )

EMBO J, 2019, 38(4)

PubMed: 30643021 ( click the link to review the publication )

J Thorac Oncol, 2019, 14(9):1556-1566

PubMed: 31108249 ( click the link to review the publication )

Cancer Res, 2019, 79(4):819-829

PubMed: 30573522 ( click the link to review the publication )

J Am Soc Nephrol, 2019, 30(8):1454-1470

PubMed: 31253651 ( click the link to review the publication )

Matrix Biol, 2019, 10.1016/j.matbio.2019.07.006

PubMed: 31323325 ( click the link to review the publication )

Cell Rep, 2019, 26(1):65-78

PubMed: 30605687 ( click the link to review the publication )

Int J Cancer, 2019, 10.1002/ijc.32487

PubMed: 31162839 ( click the link to review the publication )

Int J Cancer, 2019, 145(5):1432-1444

PubMed: 30784054 ( click the link to review the publication )

Oncogene, 2019, 38(11):1936-1950

PubMed: 30390071 ( click the link to review the publication )

Oncogene, 2019, 38(37):6399-6413

PubMed: 31324888 ( click the link to review the publication )

J Exp Clin Cancer Res, 2019, 38(1):46

PubMed: 30709379 ( click the link to review the publication )

J Exp Clin Cancer Res, 2019, 38(1):96

PubMed: 30791926 ( click the link to review the publication )

J Exp Clin Cancer Res, 2019, 38(1):481

PubMed: 31801598 ( click the link to review the publication )

Cancers (Basel), 2019, 11(1)

PubMed: 30609749 ( click the link to review the publication )

Cancers (Basel), 2019, 11(10)

PubMed: 31635301 ( click the link to review the publication )

Breast Cancer Res, 2019, 21(1):77

PubMed: 31262335 ( click the link to review the publication )

Cell Death Dis, 2019, 10(4):283

PubMed: 30911072 ( click the link to review the publication )

Signal Transduct Target Ther, 2019, 4:25

PubMed: 31637005 ( click the link to review the publication )

Cells, 2019, 8(12)

PubMed: 31795298 ( click the link to review the publication )

Cell Physiol Biochem, 2019, 53(5):805-819

PubMed: 31670920 ( click the link to review the publication )

Mol Cancer Ther, 2019, 10.1158/1535-7163.MCT-19-0181

PubMed: 31501278 ( click the link to review the publication )
Cell Prolif, 2019, 52(6):e12680

PubMed: 31454111 ( click the link to review the publication )

Neoplasia, 2019, 22(1):1-9

PubMed: 31751859 ( click the link to review the publication )

Lung Cancer, 2019, 137:85-93

PubMed: 31563735 ( click the link to review the publication )

Cancer Biol Med, 2019, 16(3):606-617

PubMed: 31565489 ( click the link to review the publication )

Artif Cells Nanomed Biotechnol, 2019, 47(1):3231-3238

PubMed: 31373232 ( click the link to review the publication )

DNA Repair (Amst), 2019, 78:37-44

PubMed: 30954901 ( click the link to review the publication )

Front Oncol, 2019, 9:1167

PubMed: 31750252 ( click the link to review the publication )

Cancer Sci, 2019, 110(11):3584-3594

PubMed: 31446643 ( click the link to review the publication )

Biochem Pharmacol, 2019, 169:113640

PubMed: 31536726 ( click the link to review the publication )

Int J Mol Sci, 2019, 20(19)

PubMed: 31546690 ( click the link to review the publication )

J Biol Chem, 2019, 294(12):4488-4497

PubMed: 30679314 ( click the link to review the publication )

Mol Pharmacol, 2019, 95(5):528-536

PubMed: 30858165 ( click the link to review the publication )

Cancer Cell Int, 2019, 19:117

PubMed: 31073278 ( click the link to review the publication )

Mol Carcinog, 2019, 10.1002/mc.23139

PubMed: 31777985 ( click the link to review the publication )

Front Pharmacol, 2019, 10:1116

PubMed: 31649529 ( click the link to review the publication )

Respir Res, 2019, 20(1-:270

PubMed: 31791326 ( click the link to review the publication )

Respir Res, 2019, 20(1):164

PubMed: 31331328 ( click the link to review the publication )

Biomed Pharmacother, 2019, 118:109169

PubMed: 31310954 ( click the link to review the publication )

J Proteomics, 2019, 195:114-124

PubMed: 30660770 ( click the link to review the publication )

Int J Mol Sci, 2019, 20(10)

PubMed: 31121829 ( click the link to review the publication )

Int J Oncol, 2019, 54(2):527-536

PubMed: 30535494 ( click the link to review the publication )

Life Sci, 2019, 224:23-32

PubMed: 30902544 ( click the link to review the publication )

J Drug Target, 2019, 27(4):451-459

PubMed: 30381967 ( click the link to review the publication )

Int J Biochem Cell Biol, 2019, 106:96-106

PubMed: 30471423 ( click the link to review the publication )
Molecules, 2019, 24(3)

PubMed: 30754629 ( click the link to review the publication )

Transl Oncol, 2019, 12(11):1516-1524

PubMed: 31450127 ( click the link to review the publication )

Eur J Pharmacol, 2019, 855:10-19

PubMed: 31028739 ( click the link to review the publication )

Eur J Pharmacol, 2019, 850:97-108

PubMed: 30753867 ( click the link to review the publication )

Eur J Pharmacol, 2019, 856:172409

PubMed: 31132355 ( click the link to review the publication )

Biosci Rep, 2019, 39(8)

PubMed: 31316001 ( click the link to review the publication )

Onco Targets Ther, 2019, 12:6033-6043

PubMed: 31440060 ( click the link to review the publication )

Biomed Res Int, 2019, 2019:3129748

PubMed: 31346515 ( click the link to review the publication )

Oncol Lett, 2019, 18(5):5621-5627

PubMed: 31620204 ( click the link to review the publication )

Oncol Lett, 2019, 18(1):368-374

PubMed: 31289508 ( click the link to review the publication )

Anticancer Res, 2019, 39(7):3785-3793

PubMed: 31262905 ( click the link to review the publication )

Exp Ther Med, 2019, 17(1):953-959

PubMed: 30651886 ( click the link to review the publication )

Oncotarget, 2019, 10(11):1171-1192

PubMed: 30838090 ( click the link to review the publication )

JCI Insight, 2019, 4(21)

PubMed: 31600169 ( click the link to review the publication )

Oncotarget, 2019, 10(26):2546-2560

PubMed: 31069016 ( click the link to review the publication )

Nat Biomed Eng, 2018, 2(4):239-253

PubMed: 30936439 ( click the link to review the publication )

Nat Commun, 2018, 9(1):4728

PubMed: 30413706 ( click the link to review the publication )

Nat Commun, 2018, 9(1):2434

PubMed: 29934552 ( click the link to review the publication )

EMBO Mol Med, 2018, 10(3)

PubMed: 29449326 ( click the link to review the publication )

Clin Cancer Res, 2018, 24(13):3097-3107

PubMed: 29506987 ( click the link to review the publication )

Clin Cancer Res, 2018, 24(16):3928-3940

PubMed: 29685880 ( click the link to review the publication )

Theranostics, 2018, 8(5):1256-1269

PubMed: 29507618 ( click the link to review the publication )

J Control Release, 2018, 275:117-128

PubMed: 29474960 ( click the link to review the publication )

J Hematol Oncol, 2018, 11(1):109

PubMed: 30157900 ( click the link to review the publication )
Oncogene, 2018, 37(12):1576-1593

PubMed: 29326440 ( click the link to review the publication )

Cancer Lett, 2018, 424:84-96

PubMed: 29524558 ( click the link to review the publication )

Sci Signal, 2018, 11(549)

PubMed: 30254057 ( click the link to review the publication )

Cancers (Basel), 2018, 10(6)

PubMed: 29925812 ( click the link to review the publication )

FASEB J, 2018, 10.1096/fj.201800011R

PubMed: 29812969 ( click the link to review the publication )

Exp Mol Med, 2018, 50(1):e435

PubMed: 29371698 ( click the link to review the publication )

Exp Mol Med, 2018, 50(4):52

PubMed: 29700289 ( click the link to review the publication )

Cell Physiol Biochem, 2018, 51(1):337-355

PubMed: 30453282 ( click the link to review the publication )

Cell Commun Signal, 2018, 16(1):77

PubMed: 30409180 ( click the link to review the publication )

Mol Cell Proteomics, 2018, 17(10):1892-1908

PubMed: 29970458 ( click the link to review the publication )

Eur J Med Chem, 2018, 144:330-348

PubMed: 29275232 ( click the link to review the publication )

Oncogenesis, 2018, 7(9):67

PubMed: 30190455 ( click the link to review the publication )

Mol Cancer Res, 2018, 16(3):543-553

PubMed: 29222171 ( click the link to review the publication )

Mol Cancer Res, 2018, 16(10):1458-1469

PubMed: 29934325 ( click the link to review the publication )

Mol Cancer Res, 2018, 16(11):1773-1784

PubMed: 29967110 ( click the link to review the publication )

Mol Cancer Res, 2018, 16(7):1185-1195

PubMed: 29724813 ( click the link to review the publication )

J Immunol, 2018, 200(8):2809-2818

PubMed: 29531172 ( click the link to review the publication )

Biochem Pharmacol, 2018, 152:327-337

PubMed: 29660315 ( click the link to review the publication )

Sci Rep, 2018, 8(1):18043

PubMed: 30575780 ( click the link to review the publication )

J Biol Chem, 2018, 293(35):13401-13414

PubMed: 29997256 ( click the link to review the publication )

Respir Res, 2018, 19(1):96

PubMed: 29784046 ( click the link to review the publication )

Cancer Manag Res, 2018, 10:5785-5798

PubMed: 30510448 ( click the link to review the publication )

Cancer Manag Res, 2018, 10:6695-6703

PubMed: 30584364 ( click the link to review the publication )

Cancer Commun (Lond), 2018, 38(1):50

PubMed: 30053908 ( click the link to review the publication )
Phytomedicine, 2018, 39:33-41

PubMed: 29433681 ( click the link to review the publication )

Int J Oncol, 2018, 52(6):2143-2154

PubMed: 29620166 ( click the link to review the publication )

Invest New Drugs, 2018, 36(6):999-1005

PubMed: 29594878 ( click the link to review the publication )

Cancer Biol Ther, 2018, 19(10):921-933

PubMed: 29856687 ( click the link to review the publication )

Cell Cycle, 2018, 17(23):2577-2592

PubMed: 30488756 ( click the link to review the publication )

Transl Oncol, 2018, 11(6):1406-1418

PubMed: 30219696 ( click the link to review the publication )

Oncol Rep, 2018, 40(4):2171-2182

PubMed: 30106444 ( click the link to review the publication )

Oncol Rep, 2018, 40(4):1937-1946

PubMed: 30106446 ( click the link to review the publication )

Oncol Rep, 2018, 40(2):775-782

PubMed: 29901173 ( click the link to review the publication )

Onco Targets Ther, 2018, 11:8455-8463

PubMed: 30555238 ( click the link to review the publication )

J Ovarian Res, 2018, 11(1):12

PubMed: 29402301 ( click the link to review the publication )

Mol Med Rep, 2018, 18(4):3882-3890

PubMed: 30106133 ( click the link to review the publication )

Oncol Lett, 2018, 15(3):2829-2838

PubMed: 29467862 ( click the link to review the publication )

Oncotarget, 2018, 9(51):29680-29697

PubMed: 30038713 ( click the link to review the publication )

Oncotarget, 2018, 9(26):18254-18268

PubMed: 29719603 ( click the link to review the publication )

Proc Natl Acad Sci U S A, 2018, 115(42):E9869-E9878

PubMed: 30275324 ( click the link to review the publication )

Nat Commun, 2017, 8(1):410

PubMed: 28871105 ( click the link to review the publication )

Autophagy, 2017, 13(7):1093-1112

PubMed: 28513279 ( click the link to review the publication )

Proc Natl Acad Sci U S A, 2017, 114(15):E3129-E3138

PubMed: 28351972 ( click the link to review the publication )

Genes Dev, 2017, 31(17):1754-1769

PubMed: 28982759 ( click the link to review the publication )

Cancer Res, 2017, 77(13):3551-3563

PubMed: 28428274 ( click the link to review the publication )

Cell Rep, 2017, 21(11):3298-3309

PubMed: 29241554 ( click the link to review the publication )

Mol Cancer, 2017, 16(1):34

PubMed: 28158983 ( click the link to review the publication )

Int J Cancer, 2017, 141(9):1921-1931

PubMed: 28710768 ( click the link to review the publication )
ACS Photonics, 2017, 5(2):487-494

PubMed: 29805987 ( click the link to review the publication )

Oncogene, 2017, 36(48):6691-6700

PubMed: 28745317 ( click the link to review the publication )

J Med Chem, 2017, 60(17):7447-7458

PubMed: 28787156 ( click the link to review the publication )

Transl Lung Cancer Res, 2017, 6(5):600-610

PubMed: 29114475 ( click the link to review the publication )

Acta Pharmacol Sin, 2017, 38(11):1501-1511

PubMed: 29022575 ( click the link to review the publication )

Oncol Rep, 2017, 38(4):2205-2210

PubMed: 28791365 ( click the link to review the publication )

Eur J Pharmacol, 2017, 821:21-28

PubMed: 29277715 ( click the link to review the publication )

Oncol Rep, 2017, 37(2):1212-1218

PubMed: 27959426 ( click the link to review the publication )

Biochem Biophys Res Commun, 2017, 493(1):213-219

PubMed: 28899783 ( click the link to review the publication )

Biochem Biophys Res Commun, 2017, 482(4):1334-1340

PubMed: 27939888 ( click the link to review the publication )

Biochem Biophys Res Commun, 2017, 486(4):1027-1033

PubMed: 28366635 ( click the link to review the publication )

Oncol Lett, 2017, 14(4):4349-4354

PubMed: 28959367 ( click the link to review the publication )

Oncotarget, 2017, 8(3):4277-4288

PubMed: 28032592 ( click the link to review the publication )

Oncotarget, 2017, 8(14):22414-22432

PubMed: 26461472 ( click the link to review the publication )

Oncotarget, 2017, 8(70):115620-115631

PubMed: 29383186 ( click the link to review the publication )

Oncotarget, 2017, 8(29):47305-47316

PubMed: 28521301 ( click the link to review the publication )

Oncotarget, 2017, 8(35):58771-58780

PubMed: 28938595 ( click the link to review the publication )

Hepatology, 2016, 64(2):488-500

PubMed: 27015352 ( click the link to review the publication )

Genome Biol, 2016, 17:80

PubMed: 27139883 ( click the link to review the publication )

Nat Commun, 2016, 7:11363

PubMed: 27193833 ( click the link to review the publication )

J Clin Invest, 2016, 126(9):3296-312

PubMed: 27482886 ( click the link to review the publication )

Nat Commun, 2016, 7:12231

PubMed: 27456471 ( click the link to review the publication )

Clin Cancer Res, 2016, 22(21):5370-5382

PubMed: 27178741 ( click the link to review the publication )

EMBO Rep, 2016, 17(5):724-38

PubMed: 27013495 ( click the link to review the publication )
J Pathol, 2016, 239(3):320-34

PubMed: 27102572 ( click the link to review the publication )

Acta Neuropathol Commun, 2016, 4(1):96

PubMed: 27586084 ( click the link to review the publication )

Mol Cancer Ther, 2016, 10.1158/1535-7163.MCT-15-0375

PubMed: 27196768 ( click the link to review the publication )

Oral Oncol, 2016, 59:12-19

PubMed: 27424178 ( click the link to review the publication )

Oral Oncol, 2016, 56:62-70

PubMed: 27086488 ( click the link to review the publication )

Biochim Biophys Acta, 2016, 10.1016/j.bbagen.2016.05.011

PubMed: 27180173 ( click the link to review the publication )

Biochim Biophys Acta, 2016, 1859(11):1449-1458

PubMed: 27412911 ( click the link to review the publication )

Clin Lung Cancer, 2016, 17(4):263-270

PubMed: 26707383 ( click the link to review the publication )

J Proteome Res, 2016, 15(12):4490-4504

PubMed: 27794612 ( click the link to review the publication )

Int J Oncol, 2016, 49(4):1427-36

PubMed: 27498706 ( click the link to review the publication )

Int J Oncol, 2016, 48(3):937-44

PubMed: 26783187 ( click the link to review the publication )

Exp Cell Res, 2016, 344(2):194-200

PubMed: 27180268 ( click the link to review the publication )

Eur J Pharmacol, 2016, 789:458-467

PubMed: 27514773 ( click the link to review the publication )

Oncol Rep, 2016, 36(2):729-36

PubMed: 27373987 ( click the link to review the publication )

Neurosurg Focus, 2016, 41(6):E14

PubMed: 27903123 ( click the link to review the publication )

PLoS One, 2016, 11(5):e0155230

PubMed: 27153109 ( click the link to review the publication )

PLoS One, 2016, 11(9):e0163149

PubMed: 27643613 ( click the link to review the publication )

Oncotarget, 2016, 7(4):3847-56

PubMed: 26716903 ( click the link to review the publication )

Oncotarget, 2016, 7(18-:25983-6002

PubMed: 27036020 ( click the link to review the publication )

Oncotarget, 2016, 7(32):52392-52403

PubMed: 27447558 ( click the link to review the publication )

Cell Res, 2015, 10.1038/cr.2015.16

PubMed: 25656847 ( click the link to review the publication )

Nat Commun, 2015, 6:6377

PubMed: 25758528 ( click the link to review the publication )

Nat Commun, 2015, 6:6240

PubMed: 25670642 ( click the link to review the publication )

J Thorac Oncol, 2015, 10.1097/JTO.0000000000000500

PubMed: 25658629 ( click the link to review the publication )
Clin Cancer Res, 2015, 10.1158/1078-0432.CCR-14-2789

PubMed: 25948633 ( click the link to review the publication )

Clin Cancer Res, 2015, 10.1158/1078-0432.CCR-15-0560

PubMed: 25964297 ( click the link to review the publication )

Proc Natl Acad Sci USA, 2015, 112(6):1839-44

PubMed: 25605917 ( click the link to review the publication )

Cell Rep, 2015, 10.1016/j.celrep.2015.04.049

PubMed: 26027934 ( click the link to review the publication )

Cancer Lett, 2015, 369(1):103-11

PubMed: 26297988 ( click the link to review the publication )

Mol Cancer Ther, 2015, 14(10-:2238-48

PubMed: 26208525 ( click the link to review the publication )

Mol Oncol, 2015, 9(2):527-43

PubMed: 25454348 ( click the link to review the publication )

Mol Cell Proteomics, 2015, 10.1074/mcp.M115.049783 mcp.M115.049783.

PubMed: 25953087 ( click the link to review the publication )

Lung Cancer, 2015, 88(1):16-23

PubMed: 25704955 ( click the link to review the publication )

J Biol Chem, 2015, 290(41):24784-92

PubMed: 26304118 ( click the link to review the publication )

J Chromatogr A, 2015, 10.1016/j.chroma.2015.04.055

PubMed: ( click the link to review the publication )

Toxicol Appl Pharmacol, 2015, 10.1016/j.taap.2015.05.001

PubMed: 25981168 ( click the link to review the publication )

Int J Oncol, 2015, 46(3):1214-24

PubMed: 25530180 ( click the link to review the publication )

Oncol Rep, 2015, 33(4):1860-6

PubMed: 25634113 ( click the link to review the publication )

Oncol Rep, 2015, 34(3):1613-9

PubMed: 26166014 ( click the link to review the publication )

Oncol Rep, 2015, 34(4):1875-82

PubMed: 26238612 ( click the link to review the publication )

Pathol Oncol Res, 2015, 10.1007/s12253-015-9916-9

PubMed: 25749811 ( click the link to review the publication )

Anticancer Res, 2015, 35(5):2795-803

PubMed: 25964559 ( click the link to review the publication )

Int J Radiat Oncol Biol Phys, 2015, 10.1016/j.ijrobp.2015.01.026

PubMed: 25823448 ( click the link to review the publication )

Oncotarget, 2015, 6(7):5118-33

PubMed: 25742786 ( click the link to review the publication )

Sci Transl Med, 2014, 6(219):219ra9

PubMed: 24431113 ( click the link to review the publication )

Mol Cell, 2014, 55(6):904-15

PubMed: 25219500 ( click the link to review the publication )

Cancer Res, 2014, 74(1):253-62

PubMed: 24165158 ( click the link to review the publication )

Elife, 2014, 3:e02523

PubMed: 24844246 ( click the link to review the publication )
Int J Cancer, 2014, 134(11):2560-71

PubMed: 24374738 ( click the link to review the publication )

Oncogene, 2014, 33(19):2495-503

PubMed: 23728339 ( click the link to review the publication )

Oncogene, 2014, 33(35):4385-95

PubMed: 24096476 ( click the link to review the publication )

MBio, 2014, 5(4):e01340-14

PubMed: 25096879 ( click the link to review the publication )

Cancer Lett, 2014, 342(1):82-91

PubMed: 24001610 ( click the link to review the publication )

Cell Death Dis, 2014, 5:e1445

PubMed: 25299770 ( click the link to review the publication )

Mol Oncol, 2014, 10.1016/j.molonc.2014.05.005

PubMed: 24908424 ( click the link to review the publication )

Mol Oncol, 2014, 9(1):260-9

PubMed: 25226813 ( click the link to review the publication )

Cell Oncol , 2014, 37(5):377-86

PubMed: 25228008 ( click the link to review the publication )

Lung Cancer, 2014, 85(2):141-6

PubMed: 24957682 ( click the link to review the publication )

Antimicrob Agents Chemother, 2014, 10.1128/AAC.02393-14

PubMed: 24663025 ( click the link to review the publication )

Colloids and Surfaces B: Biointerfaces, 2014, 123:61-7

PubMed: 25216919 ( click the link to review the publication )

Drug Metab Dispos, 2014, 42(3):318-22

PubMed: 24335466 ( click the link to review the publication )

Drug Metab Dispos, 2014, 42(11):1851-7

PubMed: 25165131 ( click the link to review the publication )

Int J Oncol, 2014, 45(1):393-400

PubMed: 24819550 ( click the link to review the publication )

Cell Cycle, 2014, 13(24):3808-17

PubMed: ( click the link to review the publication )

Am J Physiol Renal Physiol, 2014, 307(4):F435-44

PubMed: 24990892 ( click the link to review the publication )

Cancer Chemoth Pharm, 2014, 74(3):511-20

PubMed: 25038613 ( click the link to review the publication )

PLoS One, 2014, 9(4):e93651

PubMed: 24695557 ( click the link to review the publication )

PLoS One, 2014, 9(4):e95243

PubMed: 24743578 ( click the link to review the publication )

PLoS One, 2014, 9(12):e114000

PubMed: 25486409 ( click the link to review the publication )

PLoS One, 2014, 9(5):e97719

PubMed: 24874286 ( click the link to review the publication )

Horm Cancer, 2014, 289(24):17195-202

PubMed: 24778185 ( click the link to review the publication )

Exp Mol Pathol, 2014, 97(1):154-165

PubMed: 24984270 ( click the link to review the publication )
Langenbecks Arch Surg, 2014, 10.1007/s00423-014-1235-1

PubMed: 25070024 ( click the link to review the publication )

Korean J Parasitol, 2014, 52(4):439-41

PubMed: 25246725 ( click the link to review the publication )

Int J Radiat Oncol Biol Phys, 2014, 88(4):947-54

PubMed: 24606853 ( click the link to review the publication )

University of Alberta, 2014, Yahya Muhammad Fiteih

PubMed: ( click the link to review the publication )

Guangxi Medical University, 2014, Suning Huang

PubMed: ( click the link to review the publication )

JBUON , 2014, 19(2): 466-473

PubMed: ( click the link to review the publication )

Ann Oncol, 2013, 24(2):362-9

PubMed: 22967992 ( click the link to review the publication )

J Clin Endocrinol Metab, 2013, 98(6):2502-12

PubMed: 23559083 ( click the link to review the publication )

Mol Cancer Ther, 2013, 13(2):444-53

PubMed: 24258346 ( click the link to review the publication )

Mol Cancer Ther, 2013, 12(11):2541-58

PubMed: 24026012 ( click the link to review the publication )

Mol Oncol, 2013, 7(1):121-9

PubMed: 23127547 ( click the link to review the publication )

Carcinogenesis, 2013, 34(9):1994-9

PubMed: 23677069 ( click the link to review the publication )

Cell Prolif, 2013, 46(4):447-56

PubMed: 23829318 ( click the link to review the publication )

Radiother Oncol, 2013, 108(3):473-8

PubMed: 23891090 ( click the link to review the publication )

J Biol Chem, 2013, 288(48):34930-42

PubMed: 24142702 ( click the link to review the publication )

Drug Metab Dispos, 2013, 10.1124/dmd.113.054189

PubMed: 24335466 ( click the link to review the publication )

Prostate, 2013, 73(13):1453-61

PubMed: 23765757 ( click the link to review the publication )

PLoS One, 2013, 8(12):e81393

PubMed: 24339922 ( click the link to review the publication )

PLoS One, 2013, 8(12):e82625

PubMed: 24349321 ( click the link to review the publication )

Exp Mol Pathol, 2013, 94(2):386-97

PubMed: 23399805 ( click the link to review the publication )

Evid Based Complement Alternat Med, 2013, 2013:243859

PubMed: 23533466 ( click the link to review the publication )

J Genet Syndr Gene Ther, 2013, 4

PubMed: 25520884 ( click the link to review the publication )

Herpesviridae, 2013, 4(1):1

PubMed: 23342981 ( click the link to review the publication )

Oncotarget, 2013, 4(10):1698-1711

PubMed: 24091605 ( click the link to review the publication )
Tuberc Respir Dis, 2013, 75(3):95-103

PubMed: 24101933 ( click the link to review the publication )

Cell Death Differ, 2012, 19(12):1908-16

PubMed: 22722337 ( click the link to review the publication )

Int J Cancer, 2012, 131(12):2961-9

PubMed: 22514082 ( click the link to review the publication )

Int J Cancer, 2012, 131(2):334-43

PubMed: 21858806 ( click the link to review the publication )

Oncogene, 2012, 32(34):4034-42

PubMed: 22964644 ( click the link to review the publication )

Cancer Lett, 2012, 321(2):187-94

PubMed: 22343320 ( click the link to review the publication )

Cancer Sci, 2012, 103(1):7-16

PubMed: 21951556 ( click the link to review the publication )

Biochem Pharmacol, 2012, 84(4):425-31

PubMed: 22634404 ( click the link to review the publication )

Int J Mol Sci, 2012, 13(9):12000-16

PubMed: 23109896 ( click the link to review the publication )

Int J Oncol, 2012, 41(3):869-75

PubMed: 22752005 ( click the link to review the publication )

Cancer Res Treat, 2012, 44(3):202-9

PubMed: 23091447 ( click the link to review the publication )

PLoS One, 2012, 7(9):e42441

PubMed: 22957020 ( click the link to review the publication )

PLoS One, 2012, 7(12):e51549

PubMed: 23272116 ( click the link to review the publication )

Oncotarget, 2012, 2(12):1134-44

PubMed: 22193779 ( click the link to review the publication )

Mol Syst Biol, 2011, 7:486

PubMed: 21525872 ( click the link to review the publication )

Oncogene, 2011, 30(6):737-50

PubMed: 20890302 ( click the link to review the publication )

Antivir Res, 2011, 89(1):64-70

PubMed: 21094187 ( click the link to review the publication )

J Immunother, 2011, 34(4):372-81

PubMed: 21499124 ( click the link to review the publication )

Mol Biosyst, 2011, 7(12):3223-33

PubMed: 21956701 ( click the link to review the publication )

Exp Mol Pathol, 2011, 91(1):400-10

PubMed: 21565184 ( click the link to review the publication )

Vet Comp Oncol, 2011, 11(2):124-39

PubMed: 22235915 ( click the link to review the publication )

Int J Proteomics, 2011, 2011:215496

PubMed: 22091388 ( click the link to review the publication )

Carcinogenesis, 2010, 31(11):1948-55

PubMed: 20837598 ( click the link to review the publication )

产品安全说明书

EGFR抑制剂选择性比较

生物活性

产品描述

Gefitinib (ZD1839)是一种EGFR抑制剂，作用于NR6wtEGFR和NR6W细胞中的Tyr1173，Tyr992，Tyr1173和Tyr992，IC50 分别为37 nM，37nM，26 nM和57 nM。

特性

Gefitinib是有效的EGFR酪氨酸激酶抑制剂。

靶点

Tyr1173 (NR6W cells) ^[1]	Tyr1173 (NR6wtEGFR cells) ^[1]	Tyr992 (NR6wtEGFR cells) ^[1]	Tyr992 (NR6W cells) ^[1]
26 nM	37 nM	37 nM	57 nM

体外研究

Gefitinib 作用于高和低表达EGFR的细胞系，包括NR6, NR6M 和 NR6W 细胞系，有效抑制EGFR上全部酪氨酸磷酸化位点。磷酸化位点 Tyr1173和Tyr992敏感性较低，需要高浓度Gefitinib才能抑制。Gefitinib作用于NR6W细胞，高效阻断PLC-γ磷酸化, IC50为27nM。NR6wtEGFR 和NR6M细胞系具有低水平PLC-γ磷酸化， IC50 分别为 43 nM和 369 nM。Gefitinib抑制AKT磷酸化，作用于低EGFR和EGFRvIII表达的细胞系， IC50 分别为220 和263nM。Gefitinib按 0.1 到 0.5μM剂量处理，显著促进而不是废除 NR6M细胞形成集落。然而, 2μM Gefitinib 完全抑制 NR6M 集落形成。Gefitinib 作用于高和低EGFR表达的细胞系，EGF 刺激72小时后，快速抑制EGFR 和ERK 磷酸化，这种作用存在剂量依赖性。^[1]Gefitinib抑制 EGF驱动的未转化MCF10A 细胞生长，IC50为 20 nM。^[2] Gefitinib 作用于MDA-MB-231细胞，抑制EGF信号。Gefitinib严重抑制细胞数的增多，这种作用存在剂量依赖性。 ^[3]

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID
KB	NYTzOm1zT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MmrKTWM2OD1yLkC1OEDPxE1?	NV70XWN3OTZ3MU[0O\|M>
NIH3T3	MlXySpVv[3Srb36gRZN{[Xl?	NFfIepQxNjJizszN	MXSyJIg>	Ml;5SG1UVw>?	MVjJcohq[mm2aX;uJI9nKEWJRjDzeIlufWyjdHXkJIh2dWGwIHXyZmIyKGG3dH;wbI9{eGixconsZZRqd25id3n0bEBKSzVyIH;mJFAvODF2NDFOwG0>	MkDHNVY1QDB{OES=
COS7	M3fkbWZ2dmO2aX;uJGF{e2G7	Mk\CPVYh\|ryP			MlHKTY5pcWKrdHnvckBw\iCqdX3hckBLSUt{IG[2NVdHKG23dHHueEBmgHC{ZYPz[YQ>	NGPM[VgyPzF5OEeyNi=>
A549	M1voNWN6fG:2b4jpZ{BCe3OjeR?=		Mk\DPVYhcA>?	MXzEUXNQ	NYThXHpwUUN3ME2xN{42QSEQvF2=	NILjPJgyQDNzM{iwOy=>
K562	M2XWRmN6fG:2b4jpZ{BCe3OjeR?=		M37sV\|k3KGh?	NGDHPZRFVVOR	NVnUcHZUUUN3ME25MlM3KM7:TR?=	NE[zN\|kyQDNzM{iwOy=>
MDA-MB-231	MonXR5l1d3SxeHnjJGF{e2G7		MWC5OkBp	MWnEUXNQ	MUXJR\|UxRTN4Lk[xJO69VQ>?	M1q0OVE5OzF\|OEC3
MOLT4	MnPTR5l1d3SxeHnjJGF{e2G7		M37KUlk3KGh?	MkHjSG1UVw>?	NFPWdm1KSzVyPUG1MlAzKM7:TR?=	NUPsbG02OTh\|MUO4NFc>
MCF7	NETuVYNEgXSxdH;4bYMhSXO\|YYm=	M3LRcFUxKM7:TR?=	NWHEdHNQPzJiaB?=		NHq0TXhKSzVyPUGyMlA2KM7:TR?=	MoO5NVg4PzF6MUm=
BT474	M2nXdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NX3GXJZbPzJiaB?=		MnflRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCEVES3OEBk\WyuczDveoVz\XiycnXzd4lv\yCHUlLiNkB4cXSqIFXDOVAhd2ZiMD6zJO69VQ>?	NIXNW2kyQTB{OESyOC=>
HN5	M2nSO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NFXE[WM4OiCq		MkH3RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCKTkWgZ4VtdHNib4\ldoV5eHKnc4PpcochTUeIUjD3bZRpKEWFNUCgc4YhOC5yMTFOwG0>	NXHseZBzOTlyMki0NlQ>
BA/F3	NGTpN4JEgXSxdH;4bYMhSXO\|YYm=		NX3R[FFIPzJiaB?=		MV;DfZRwfG:6aXPpeJkh[WejaX7zeEBud3W\|ZTDCRU9HOyClZXzsd{BmgHC{ZYPzbY5oKEWJRmKgUFg2QFJibYX0ZY51KHerdHigTWM2OCCxZjCwMlAyODhizszN	M3TzW\|E6OjN7MkK5
NIH3T3	NIfjZ3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NUHUbXZ6PzJiaB?=		NGjsRllIem:5dHigbY5pcWKrdHnvckBw\iCvb4Xz[UBPUUhxM2SzJINmdGy\|IHX4dJJme3Orbneg[ZJDOiCpZX7lJJdqfGhiSVO1NEBw\iByLkW0JO69VQ>?	NU\ZRWJjOTl4NkWzO\|c>
MCF7 MX	MkfuSpVv[3Srb36gRZN{[Xl?		M2fXRVMxKG2rbh?=		M3TzT2lvcGmkaYTpc44hd2ZiQlPSVEBmgHC{ZYPz[YQhf2m2aDDJR\|UxKG:oIEGuNUDPxE1?	MmK0NVk6OzJ7NkC=
A431	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NFuwVmoyOCEQvF2=	NIPMVWE4OiCq		M4PQNmdKPTB;MD61NVQh\|ryP	MVWxPVk3QTR4NR?=
A431	M{PMdmtqdmG\|ZTDBd5NigQ>?	MUKwMlEh\|ryP	MWexJIg>		Mni3TY5pcWKrdHnvckBw\iCHR1[tbY5lfWOnZDDFS2ZTKHCqb4PwbI9zgWyjdHnvci=>	NXrWdZV5OTl7Nkm0OlU>
A431	NEL2TVRMcW6jc3WgRZN{[Xl?	NFGxc\|UyODBizszN	NWT1eHNWOTBibXnu		NH;TeWlRem:ub37n[YQhcW6qaXLpeI9zgSCjY4Tpeol1gSCxZjDFS2YucW6mdXPl[EBGT0[UIIDoc5NxcG:{eXzheIlwdg>?	Ml3CNVk6Pjl2NkW=
Sf9	M37XOWtqdmG\|ZTDBd5NigQ>?		M37hXlExKG2rbh?=	NIDj[oVFVVOR	Mnv3TY5pcWKrdHnvckBw\iCHR1\SJIV5eHKnc4Pl[EBie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJJJm[2WydH;yJIF2fG:yaH;zdIhwenmuYYTpc44hf2m2aDDJR\|UxKG:oIECuNFM{KM7:TR?=	MoL3NlAxPTZ2MkW=
NCI-H1975	M3\Idmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M33WR\|Uh\|ryP	M{jtNVczKGh?		NHPl[ldKSzVyPUiuNlYh\|ryP	M1m5e\|IxOTVzNkew
NCI-H1975	MW\LbY5ie2ViQYPzZZk>	NVnHXWx1OTBizszN			MlLLTY5pcWKrdHnvckBw\iCHR1\SJIF2fG:yaH;zdIhwenmuYYTpc44>	NX;jOXdDOjBzNUG2O\|A>
NCI-H1975	NYH4bVFQTnWwY4Tpc44hSXO\|YYm=	MXixNEDPxE1?			MoHkTY5pcWKrdHnvckBw\iCHUlLCNkBifXSxcHjvd5Bpd3K7bHH0bY9v	NYflNZRuOjBzNUG2O\|A>
NCI-H1975	NIPObIxHfW6ldHnvckBCe3OjeR?=	M{XsSVUh\|ryP	NFzWeZE1QCCq		M3vidWlv\HWldHnvckBw\iCjcH;weI9{cXNiYYPz[ZN{\WRiYYOgZYN1cX[jdHnvckBw\iClYYPwZZNmNTN?	MUSyNFE2OTZ5MB?=
A375	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MlX1OFghcA>?		MmPlTWM2OD1{MD61OUDPxE1?	NVn0eVA4OjB\|MES1N\|c>
SMMC7721	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MmDSOFghcA>?		M17mRmlEPTB;M{OuNVIh\|ryP	NEfDdGYzODNyNEWzOy=>
DU145	M{KyO2N6fG:2b4jpZ{BCe3OjeR?=		NGPuO5o2KGR?	MlfLSG1UVw>?	MkHXTWM2OD12Mj6xO{DPxE1?	NGTSe24zODR4NkW1OS=>
MIAPaCa2	NULyS2JlS3m2b4TvfIlkKEG\|c3H5		NX60eodGPSCm	NHzVUXBFVVOR	Mlf1TWM2OD13MD62NkDPxE1?	MljNNlA1PjZ3NUW=
PANC1	MmLsR5l1d3SxeHnjJGF{e2G7		M{nvblUh\A>?	NUjGWYN6TE2VTx?=	MorRTWM2OD12MD60NkDPxE1?	NIToW4UzODR4NkW1OS=>
PC9	M3;OW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHmxNoZCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JGVITlJvZHXmbYNq\W62IHj1cYFvKFCFOTDj[YxteyC5aYToJGVEPTBib3[gNE4xOTdizszN	MVyyNVIxQDhyMh?=
PC9	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlrLRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDndo94fGhvcnXzbZN1[W62IHj1cYFvKFCFOTDj[YxteyCneIDy[ZN{cW6pIFXHSnIhTTd2Nm;BO\|UxN1R5OUDNJI12fGGwdDD3bZRpKEWFNUCgc4YhPyEQvF2=	M2POOFIyOjB6OECy
PC3	MojIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmfVNVAh\|ryP	M33kZlczKGh?	M1TuZWROW09?	NUCzWopPUUN3ME23MlQh\|ryP	MUeyNVM2OzV2Nh?=
MDA-MB-468	NECzT4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NYT0c\|RSOTByIN88US=>	MWG0PEBp	MXvEUXNQ	M1y1bmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5	NIXvTpczOTR{OU[zNi=>
Plasmodium falciparum					M{K0[JFJXFNicILv[oltcW6pIH\vdkBqdmirYnn0c5J{KG:oIGDsZZNud2SrdX2g[oFt[2myYYL1cUBxem:uaX\ldoF1cW:w	M{O4PVIyQDF5MES1
NCI-H1993	NVHCbZB1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MXu3NkBp	NYDJWIg{TE2VTx?=	MmDGTWM2OD1yLkGg{txO	MoDKNlE6OTZ2M{O=
NCI-H292	MmnGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MYW3NkBp	NWnZbmQ2TE2VTx?=	NUnFc3pXUUN3ME2wMlAzKM7:TR?=	MXeyNVkyPjR\|Mx?=
A431	MlqzT4lv[XOnIFHzd4F6		NIPadpMzKGh?	MYDEUXNQ	MWjJcohq[mm2aX;uJI9nKEWJRmKgdIhwe3Cqb4L5cIF1cW:wIHnuJGVITi2\|dHnteYxifGWmIHj1cYFvKEF2M{Gge4l1cCCLQ{WwJI9nKDBwMECxJO69VQ>?	M{nRZ\|IzOTBzMUOy
MCF7	NHGyeVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MnW0NVAxyqEQvHevcWw>	M2DUeFQ5KGh?	MYPEUXNQ	NI\Hb49CdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlch[2WubIOgc5ZmemW6cILld5NqdmdiRVfGVkBo\W6nIIfpeIghUUN3MDDv[kAyOi5yNTFOwG0>	NF;pTVczOjFzOUGzNC=>
BT474	NHHD[HNEgXSxdH;4bYMhSXO\|YYm=	M3fL[lExKM7:TR?=	Mn7qOFghcA>?		NHrqVGdEgXSxdH;4bYNqfHliYXfhbY5{fCC\|ZYL1cU1{fGG{dnXkJIh2dWGwIFLUOFc1KGOnbHzz	NFvTU5MzOjF\|OEOwPC=>
MCF7	Mm[zR5l1d3SxeHnjJGF{e2G7	Mm\RNVAh\|ryP	M4LyXFQ5KGh?		MWPDfZRwfG:6aXPpeJkh[WejaX7zeEB{\XK3bT3zeIFzfmWmIHj1cYFvKE2FRkegZ4VtdHNib4\ldk1mgHC{ZYPzbY5oKEW{YlKyJINmdGy\|	Mme2NlIyOzh\|MEi=
HCC827	NIDsSnhMcW6jc3WgRZN{[Xl?	MlezNE4yOjVizszN	NHf6VIYzPCCq	NUjEco9LTE2VTx?=	NUPzdnUxUW6qaXLpeIlwdiCxZjDFS2ZTKGSnbDDFO\|Q3NUF5NUCgcZV1[W62IGmxNFY5KGG3dH;wbI9{eGixconsZZRqd25?	MVqyNlM{QTN2Mh?=
HCC827	MkS5T4lv[XOnIFHzd4F6	NX7qPFdvOC5zMkWg{txO	M3W4XlI1KGh?	MVvEUXNQ	NFfEVGRKdmirYnn0bY9vKG:oIFXHSnIh\GWuIFW3OFYuSTd3MDDteZRidnRvbXXkbYF1\WRiRYLrJJBpd3OyaH;yfYxifGmxbh?=	MlHxNlI{Ozl\|NEK=
HCC827	NGOxWINMcW6jc3WgRZN{[Xl?	MnO1NE4yOjVizszN	NEPXXmUzPCCq	M1H2T2ROW09?	MnjSTY5pcWKrdHnvckBw\iCHR1\SJIRmdCCHN{S2MWE4PTBibYX0ZY51NW2nZHnheIVlKEGtdDDwbI9{eGixconsZZRqd25?	NEnRcmEzOjN\|OUO0Ni=>
A431	M1X0eGtqdmG\|ZTDBd5NigQ>?	MkO5NVAxKM7:TR?=	NVL3VoVFOzBibXnu		M4XXUGlvcGmkaYTpc44hd2ZiRVfGVkBl\XKrdnXkJIZzd21iaIXtZY4hSTR\|MTDj[YxtKG2nbXLyZY5mKGG\|c3Xzd4VlKGG\|IHnubIljcXSrb36gc4YheG:ueT3HcJUuXHm{IIDoc5NxcG:{eXzheIlwdiC5aYToJGlEPTBib3[gNU4xQCEQvF2=	NY\qT\|lNOjJ4OUi3PFI>
H460	NWXyWm57S3m2b4TvfIlkKEG\|c3H5		MoHLO\|IhcA>?		MnrJTWM2OD13LkW5JO69VQ>?	MYSyNlczPzR2OR?=
HT-29	NXqyZm1oS3m2b4TvfIlkKEG\|c3H5		Mn3IO\|IhcA>?		NWP5PYF6UUN3ME2zMlM3KM7:TR?=	MYSyNlczPzR2OR?=
SGC7901	NEDvSWlEgXSxdH;4bYMhSXO\|YYm=		M1npV\|czKGh?		MofKTWM2OD1zMD6yOkDPxE1?	MnjVNlI4Ojd2NEm=
A498	MlHWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmLYRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCDNEm4JINmdGy\|IHX4dJJme3OrbnegSWdHWiCjbnSgV3JEKHerdHigTWM2OCCxZjC4MlYh\|ryP	NYnsR2pIOjJ6MUi4OFg>
Calu3	NUfzeY57S3m2b4TvfIlkKEG\|c3H5	MUGxNEDPxGdxbVy=	MWi3NkBp		NIPSSFhKSzVyPUGuOkDPxE1?	NHHr[WwzOzFzNkG2PC=>
FADU	M1;VU2N6fG:2b4jpZ{BCe3OjeR?=	M1z6VVExKM7:Zz;tUC=>	NYXr[XJPPzJiaB?=		MUPJR\|UxRTBwMEWg{txO	NELpWlAzOzFzNkG2PC=>
HCC827	MV;DfZRwfG:6aXOgRZN{[Xl?	MVexNEDPxGdxbVy=	NGWwSXc4OiCq		MXrJR\|UxRTBwMECxOUDPxE1?	M4naUlI{OTF4MU[4
PC9	NVTVXIhwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M2j5NlExKM7:Zz;tUC=>	NYfONVVnPzJiaB?=		NWfvXo1VUUN3ME2wMlAyPCEQvF2=	Ml7FNlMyOTZzNki=
Sf9	MnrZT4lv[XOnIFHzd4F6		M{DwZlEhcA>?	MmOySG1UVw>?	M1iye2lvcGmkaYTpc44hd2ZiaIXtZY4hT1OWLYTh[4dm\CCHR1\SJGw5OzSUIH31eIFvfCCneIDy[ZN{\WRid3n0bEBKSzVyIH;mJFAvODF3IN88US=>	MUOyN\|YyOTZ7MR?=
16HBE14o-	MVTDfZRwfG:6aXOgRZN{[Xl?	M3zPcFExKM7:TR?=	MX[3NkBp	NEHoOmdFVVOR	M1jmcGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJFE3UEKHMUTvMUBk\WyuczDoZZJjd3Krbnege4lt\CC2eYDlJGVITlJiYYPz[ZN{\WRiYYOg[5Jwf3SqIHnubIljcXSrb36ge4l1cCCLQ{WwJI9nKDF{LkexJO69VQ>?	MnXRNlM3Pjh2NEG=
NCI-H1975	M4PhW2N6fG:2b4jpZ{BCe3OjeR?=	MkKxNVAh\|ryP	MknFO\|IhcA>?	MlqwSG1UVw>?	NFzlZ5VEgXSxdH;4bYNqfHliYXfhbY5{fCCpZX\peIlvcWJvcnXzbZN1[W62IHj1cYFvKE6FST3INVk4PSClZXzsd{Bp[XKkb4LpcochTUeIUjDMPFU5Wi:WN{mwUUBld3WkbHWgcZV1[W62IHHzd4V{e2WmIHHzJIdzd3e2aDDpcohq[mm2aX;uJJdqfGhiSVO1NEBw\iB4LkmxO{DPxE1?	Ml3CNlM3Pjh2NEG=
16HBE	Ml\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MU[3NkBp	M1PjXmROW09?	M33nSmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iMU\IRmUh[2WubIOg[ZhxemW\|c3nu[{B4cWymIIT5dIUhTUeIUjD3bZRpKEmFNUCgc4YhOS54MEGg{txO	MoWxNlM4QTJ\|MUi=
16HBE	Mo\ySpVv[3Srb36gRZN{[Xl?	NVPydWt6OTByIN88US=>	NVrQcFJkOTVyIH3pci=>	Mn;iSG1UVw>?	MYfJcoR2[3Srb36gc4Yhdmm2cnnjJI95cWSnIIDyc4R2[3Srb36gbY4hcHWvYX6gNVZJSkViY3XscJMh\XiycnXzd4lv\yC5aXzkJJR6eGViRVfGVi=>	MWGyN\|c6OjNzOB?=
A549	NVfkUo9TT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NF20dW44OiCq	MojwSG1UVw>?	NFjXdmZCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JJdqdGRidInw[UBGT0[UL3utVoF{KGSncHXu[IVvfCCqdX3hckBCPTR7IHPlcIx{KHerdHigTWM2OCCxZjC0MlYzPiEQvF2=	M1PPVlI{Pzl{M{G4
SH-SY5Y	NWTaU2x7S3m2b4TvfIlkKEG\|c3H5		M{jU[lczKGh?		NH;hS3FKSzVyPUG4MlIyKM7:TR?=	M2K4S\|I{QDdzOUC5
LoVo	Mny5T4lv[XOnIFHzd4F6		NI\ZSVQzKCCq	NF7JXmlFVVOR	MWfJcohq[mm2aX;uJI9nKEWJRmKgdIhwe3Cqb4L5cIF1cW:wIIfpeIghUUN3MDDv[kAxNjB4MjFOwG0>	Mlu0NlM6OzB7OUS=
PC9	MYjLbY5ie2ViQYPzZZk>		M3j4VFIhcA>?	MoXISG1UVw>?	M3q4SWlvcGmkaYTpc44hd2ZiRVfGVkBmgG:wIEG5JIRmdGW2aX;uJIFkfGm4YYTpcochdXW2YX70JJBpd3OyaH;yfYxifGmxbjDpckBpfW2jbjDQR\|kh[2WubIOge4l1cCCLQ{WwJI9nKDBwMEC4O{DPxE1?	MnXONlM6OzB7OUS=
HCC827	MmLJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NHHzR3U4OiCq		M1HJcGlEPTB;MD6wNVIh\|ryP	NXnsbIhmOjN7N{OxOlg>
A549	MkGwT4lv[XOnIFHzd4F6	NXLBXoJ5OSEQvF2=	M1;VN\|EhcA>?	NWGwUZhPTE2VTx?=	MX7Jcohq[mm2aX;uJI9nKEWJRmKgZZV1d3Cqb4PwbI9zgWyjdHnvckB4cXSqIFnDOVAhd2ZiMD6wN\|k6KM7:TR?=	MUOyN\|k5QDN3NB?=
A549	Ml\4SpVv[3Srb36gRZN{[Xl?	M3ztTlEh\|ryP	MlvVNUBp	NEjHV\|VFVVOR	Mn\jR4VtdHWuYYKgeZB1[Wun	NV\tUIRyOjN7OEizOVQ>
HCC827	MmqyT4lv[XOnIFHzd4F6	MlL4NE42KM7:TR?=	NEHxe4kzKGh?	MmTBSG1UVw>?	M2[1bGlvcGmkaYTpc44hd2ZiRVfGVkBxcG:\|cHjvdplt[XSrb36gbY4h\2WoaYTpcoljNXKnc3nzeIFvfCCqdX3hckBJS0N6MkegZ4VtdHN?	M2i3TlI{QTl\|M{K4
HCC827	NXy2XJc5TnWwY4Tpc44hSXO\|YYm=	MXSwMlUh\|ryP	NFTldYQzKGh?	MYPEUXNQ	MUHJcohq[mm2aX;uJI9nKGNvTXX0JJBpd3OyaH;yfYxifGmxbjDpckBo\W[rdHnubYIuemW\|aYP0ZY51KGi3bXHuJGhESzh{NzDj[Yxtew>?	NFTCT\|QzOzl7M{OyPC=>
HCC827	NEHvb\|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MnLhNVAh\|ryP	M1n3eVczKGh?	MljZSG1UVw>?	MnrTRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDn[YZqfGmwaXKtd4Vve2m2aY\lJIh2dWGwIFjDR\|gzPyClZXzsd{Bp[XKkb4LpcochTUeIUjDFO\|Q3KHSxIFG3OVAh\GWuZYTpc44hf2m2aDDJR\|UxKG:oIECuNFA2QDFizszN	NGLCSmkzPDB3M{[3OC=>
A431	NH\WSWNMcW6jc3WgRZN{[Xl?	M2LqRlExOCEQvF2=	M{X4VlMxKG2rbh?=		MXrJcohq[mm2aX;uJI9nKEWJRmKgbY4he2inZDDt[Y1jemGwZTD2[ZNq[2ynczD3bZRpKEmFNUCgc4YhOS5zIN88US=>	NWfNR49zOjRyOUS0N\|I>
BCRP-MDCK2	MUTGeY5kfGmxbjDBd5NigQ>?	Mm\aNU45KM7:TR?=	MnPEO\|IhcA>?	MYjEUXNQ	MWDJcoNz\WG\|ZTDv[kBxdGG\|bXGgcYVu[nKjbnWg[ZhxemW\|c3nvckBw\iCEQ2LQJIV5eHKnc4PpcochemWyb4L0[ZIh\2WwZTDHSnA>	NFrKc4wzPDF6NEKxNy=>
BCRP-MDCK2	M3n5PWZ2dmO2aX;uJGF{e2G7	MU[xMlgh\|ryP	MkKyO\|IhcA>?	MVnEUXNQ	NGjLWoNT\WS3Y4Tpc44hd2ZicHzhd41iKG2nbXLyZY5mKGW6cILld5Nqd25ib3[gRmNTWCCneIDy[ZN{cW6pIILldI9zfGW{IHflcoUhT0[S	NVm5bGZROjRzOESyNVM>
MDCK	NHv5NoJEgXSxdH;4bYMhSXO\|YYm=		MlTQO\|IhcA>?	Ml\nSG1UVw>?	NWDzfo5QT0l3ME2xMlQ2KM7:TR?=	M1TiO\|I1OTh2MkGz
MDCK2	M1G5UWZ2dmO2aX;uJGF{e2G7	NE\Eb44yNjhizszN	M4j6dFczKGh?	MVfEUXNQ	M3;X[GlvcGmkaYTpc44hd2ZiaIXtZY4hSkOUUDDlfJBz\XO\|ZXSgZZN{\XO\|ZXSgZZMhUG:nY3jzeEA{OzN2MjDhZ4N2dXWuYYTpc44hf2m2aDDJR\|UxKG:oIEOuNVkh\|ryP	Mn3zNlQyQDR{MUO=
A431	MUXDfZRwfG:6aXOgRZN{[Xl?		NYjEUll7PzJiaB?=	NYPTbI9oTE2VTx?=	Mm[3R5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVQ{OSClZXzsd{BmgHC{ZYPzbY5oKEWJRmKge4l1cCCLQ{WwJI9nKDBwNUWg{txO	NV3veXl1OjR2MUGxNlM>
Calu3	MlPzR5l1d3SxeHnjJGF{e2G7		NGnkdJc4OiCq	MVHEUXNQ	NVHIZZVOS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hS2GudUOgZ4VtdHNiZYjwdoV{e2mwZzDISXIzKHerdHigTWM2OCCxZjCwMlk6KM7:TR?=	MUmyOFQyOTF{Mx?=
KB	MkW2T4lv[XOnIFHzd4F6	M4LEb\|ExKM7:TR?=	NEDGWm8yKGh?	NVfGXWh5TE2VTx?=	NWrYVmkxUW6qaXLpeIlwdiCxZjDFS2Yue3SrbYXsZZRm\CCjdYTvdIhwe3Cqb4L5cIF1cW:wIH;mJGVITlJid3n0bEBKSzVyIH;mJFAvODJ3IN88US=>	MojqNlQ1OTFzMkO=
BEAS2B	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MX:1NEDPxE1?	M3nVU\|czKGh?	NHHKOmxFVVOR	MYHJR\|UxRTF\|Lkm0JO69VQ>?	NV3YPZFIOjR4MEe1PVE>
NCI-H1975	NXT1eIhyTnWwY4Tpc44hSXO\|YYm=	MmXHNVAxKM7:TR?=	NVLF[npUOTVyIH3pci=>	MUHEUXNQ	NX3sfGtTUW6mdXP0bY9vKG:oIF7PJJBzd2S3Y4Tpc44hcW5iaIXtZY4hVkOLLVixPVc2KGOnbHzzJIhiemKxcnnu[{BGT0[UIFy4OVhTN1R5OUDNJI12fGGwdB?=	NUe4RWxkOjR4MEe1PVE>
Hela	NXHLd25sT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NGricnozPCCq	NFXoO2xFVVOR	M13z[mlEPTB;Mj62O{DPxE1?	NVXD[lRWOjR5M{GyPFE>
HepG2	M2rrZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NXPUVFlTOjRiaB?=	NXLvOnk1TE2VTx?=	MmPPTWM2OD14LkSyJO69VQ>?	NVLHOJlzOjR5M{GyPFE>
Sf9	Mmn6T4lv[XOnIFHzd4F6		NFfnZmEyOCCvaX6=	MYTEUXNQ	NETLTIFKdmirYnn0bY9vKG:oIHH1eI9xcG:\|cHjvdplt[XSrb36gc4YhemWlb33ibY5idnRiaHnzMZRi\2enZDDFS2ZTKCijbXnuc{Bi[2mmIE[0OU0yOTh4KTDlfJBz\XO\|ZXSge4l1cCCLQ{WwJI9nKDBwMEKg{txO	NXS4NlBrOjR5M{GyPFE>
SW620	MljLR5l1d3SxeHnjJGF{e2G7		NHfBS4Q1QCCq	NYrRdWJzTE2VTx?=	MX\JR\|UxRTJ6LkKg{txO	NH2wepMzPDlyMEW5OC=>
HCC827	MkjDSpVv[3Srb36gRZN{[Xl?	M1WwWVAvPSEQvF2=	NFLCcWUzKGh?	NV;PbG0zTE2VTx?=	MVnkc4V{KG6xdDDpcohq[mm2IHOtUYV1KGG\|c3Xzd4VlKGG\|IHnubIljcXSrb36gc4YhSUuWIIDoc5NxcG:{eXzheIlwdg>?	NWTYfpQzOjN7OUOzNlg>
HCC827	Mnf4SpVv[3Srb36gRZN{[Xl?	NXLEOI9JOC53IN88US=>	M1u3elIhcA>?	NV:5[mF2TE2VTx?=	NYf0S\|dN\G:nczDuc5QhcW6qaXLpeEBkNU2ndDDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIIC0OE81OiCyaH;zdIhwenmuYYTpc44>	NVTIXnZxOjN7OUOzNlg>
HCC827	MmrFR5l1d3SxeHnjJGF{e2G7	M364TlAvPSEQvF2=	NG\0Wo04OiCq	MnjzSG1UVw>?	NUHpfVNHcGG\|IH7vJIN6fG:2b4jpZ4l1gQ>?	MoHzNlM6QTN\|Mki=
NCI-H1975	M1Wwb2Z2dmO2aX;uJGF{e2G7	NGLYRZgyOCEQvF2=	NE\GWlY5KGh?	NGT3bHdFVVOR	NFXuPGxld2W\|IH7veEBqdmirYnn0bUBGT0[UIHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiCHUlugdIhwe3Cqb4L5cIF1cW:w	MXmyN\|EyPjF4OB?=
A431	MmPVT4lv[XOnIFHzd4F6	MV2xJO69VQ>?	NIH6UJYyKGh?	M3;2PGROW09?	NFj4VY9p[XNibn:gbZJz\X[ncoPpZoxmKGmwaHnibZRqd25ib3[gSWdHWiCjdYTvdIhwe3Cqb4L5cIF1cW:w	M4fpXFI1QTByNUm0
LNCaP	MnzYSpVv[3Srb36gRZN{[Xl?	NX;sRVNlOTBizszN	NH7qVHMzcCCxcjC0JIg>	M3;BPGROW09?	MlXF[I9meyCwb4SgbY5pcWKrdDDheZRweGixc4Doc5J6dGG2aX;uJI9nKGmvbYXuc5B2emmoaXXkJIZt[WdvdHHn[4VlKEKveDDhd5Nme3OnZDDhd{BqdmOxcoDvdoF1cW:wIH;mJHs{OlCfQWTQ	M3TUcVE5PjZ5M{Gy
H1975	NV3vRYdqU2mwYYPlJGF{e2G7	M3LmdVEh\|ryP	NH:1eXYzPCCq	NH20SFlFVVOR	NVLQS3RE\G:nczDuc5QhcW6qaXLpeEBGT0[UIIDoc5NxcG:{eXzheIlwdiCrbjDoeY1idiCKMUm3OUBk\WyuczDoZZJjd3KrbnegSWdHWiCOOEW4Vk9VPzlyTTDteZRidnR?	MkHINlQ3ODd3OUG=
H1975	NVPzcGl3TnWwY4Tpc44hSXO\|YYm=	NIfSV2syKM7:TR?=	MX[yOEBp	MVnEUXNQ	M1;xOIRw\XNibn;0JIlvcGmkaYSgSXJMKHCqb4PwbI9zgWyjdHnvckBqdiCqdX3hckBJOTl5NTDj[YxteyCqYYLic5JqdmdiRVfGVkBNQDV6Uj;UO\|kxVQ>?	NFnZc3czPDZyN{W5NS=>
HCC827	NYnQVm9EU2mwYYPlJGF{e2G7	MmXyNE4yOSEQvF2=	M4riZ\|EhcA>?	NHXUboZFVVOR	NF;aUoxp[XNibn:gbZJz\X[ncoPpZoxmKGmwaHnibZRqd25ib3[gSWdHWiCjc4Pld5Nm\CCjczDy[YNwfmW{eTDv[kBGT0[UIHH1eI9xcG:\|cHjvdplt[XSrb36=	M1;IS\|I1OTJ2OEm4
H1975	NFXUUmFMcW6jc3WgRZN{[Xl?	NX\xSlJCOC5\|MzFOwG0>	NVXiN4dvOiCq	NIq5T3RFVVOR	M{KxUoRw\XNibn;0JIlvcGmkaYSgSWdHWiCOOEW4Vk9VPzlyTTDkc5VjdGVibYX0ZY51KGG\|c3Xzd4VlKGG\|IILl[JVkfGmxbjDpckBCU1RicHjvd5Bpd3K7bHH0bY9v	NES3ZoozPDF{NEi5PC=>
H1975	NGnRWpRMcW6jc3WgRZN{[Xl?	MmntNE4{OyEQvF2=	MknwNkBp	NGO5bm1FVVOR	Mknw[I9meyCwb4SgbY5pcWKrdDDFS2ZTKEx6NUjSM3Q4QTCPIHTveYJt\SCvdYThcpQh[XO\|ZYPz[YQh[XNicnXkeYN1cW:wIHnuJGVTUyCyaH;zdIhwenmuYYTpc44>	MUeyOFEzPDh7OB?=
H1975	NFTkfGFMcW6jc3WgRZN{[Xl?	NU\JbZZyOC5\|MzFOwG0>	NEfQfIEzKGh?	M3HuVGROW09?	M1PlbYRw\XNibn;0JIlvcGmkaYSgSWdHWiCOOEW4Vk9VPzlyTTDkc5VjdGVibYX0ZY51KHCqb4PwbI9zgWyjdHnvci=>	NV[5dVgzOjRzMkS4PVg>
H1975	MYPLbY5ie2ViQYPzZZk>	MYOwMlEzPSEQvF2=	Mn3kNlQhcA>?	NVexPIhUTE2VTx?=	MXLkc4V{KG6xdDDpcohq[mm2IFXHSnIhVDh3OGKvWFc6OE1ibYX0ZY51KFlzME[4JIF2fG:yaH;zdIhwenmuYYTpc44>	MWKyNlM{QTN2Mh?=
H1975	MYfLbY5ie2ViQYPzZZk>	MmfMNE42KM7:TR?=	MkDTNlQhcA>?	MUTEUXNQ	NH3rWlBld2W\|IH7veEBqdmirYnn0JGVITlJiTEi1PHIwXDd7MF2gcZV1[W62LX3l[IlifGWmIFXyb{BxcG:\|cHjvdplt[XSrb36=	M2rqdFIzOzN7M{Sy
H1975	NEjzbpBMcW6jc3WgRZN{[Xl?	NYnEdY9wOC53IN88US=>	MlXQNlQhcA>?	NYfPRW5GTE2VTx?=	NIjqVlFld2W\|IH7veEBqdmirYnn0JGVITlJiTEi1PHIwXDd7MF2gcZV1[W62LX3l[IlifGWmIFHreEBxcG:\|cHjvdplt[XSrb36=	M3rnZlIzOzN7M{Sy
MIAPaCa2	MljWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MXSyMlUh\|ryP	MV:3NkBp	NWC5WJk4TE2VTx?=	MVLoZZMhdm9iZ4Lve5RpKGmwaHnibZRqd25?	NYjZXmNPOjB2Nk[1OVU>
MIAPaCa2	NHvxT\|hEgXSxdH;4bYMhSXO\|YYm=	M3vIc\|Eh\|ryP	NHTVUJIyOCCm	MUDEUXNQ	Mo[3bIF{KG6xIHP5eI91d3irY3n0fUBie3Onc4Pl[EBieyC\|dYDwdoV{e2mxbjDv[kBkd2yxbomg[o9zdWG2aX;u	M4DHSlIxPDZ4NUW1
MIAPaCa2	MkDsRZBweHSxc3nzJGF{e2G7	NUezSolkOTBizszN	MXSyOIghd3JiNEigbC=>	M175cWROW09?	MkP6[I9meyCwb4SgbY5lfWOnIHHwc5B1d3Orcx?=	NI\sOVczODR4NkW1OS=>
MIAPaCa2	M3;pN2Fxd3C2b4Ppd{BCe3OjeR?=	NF;DN48zOCEQvF2=	NH7pRngzPCCq	MVzEUXNQ	MoT6[I9meyCwb4SgbY5lfWOnIHHwc5B1d3OrczDhd5Nme3OnZDDhd{Bk[XOyYYPlJFMh[WO2aY\heIlwdg>?	NITBeYEzODR4NkW1OS=>
EoL-1	MkXUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MlnMTWM2OD13LkG3JI5O	NEX1XXRUSU6JRWK=
NCI-H720	NX7iW4JxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGrp[I9KSzVyPUK2MlkzKG6P	MYXTRW5ITVJ?
NCI-SNU-5	NVLmWG1[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXnDW4hPUUN3ME2yPE4yQSCwTR?=	NGfqPFZUSU6JRWK=
EW-3	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXHHVmxUUUN3ME20Ok4xPCCwTR?=	NXjzWYx1W0GQR1XS
HCC2218	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWHJR\|UxRTVyLkW5JI5O	Mn23V2FPT0WU
HuO-3N1	M4fJdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MUfJR\|UxRTV4LkC5JI5O	MlTKV2FPT0WU
DB	MknSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NH\HZnhKSzVyPU[wMlk3KG6P	M1LpeXNCVkeHUh?=
HSC-4	M3jlUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3HC[mlEPTB;NkGuOVMhdk1?	NV\T[JZPW0GQR1XS
DOK	MnT0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnLTTWM2OD17Mz62NkBvVQ>?	MorOV2FPT0WU
H9	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NETpfFBKSzVyPUGzO{4zKG6P	NIHaOJRUSU6JRWK=
NCI-H292	NWnIR3JJT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NVHL[mlVUUN3ME2xOlIvPjZibl2=	MYLTRW5ITVJ?
HSC-2	Ml:4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NIfzTo9KSzVyPUG2OU42PyCwTR?=	Mm\XV2FPT0WU
LU-65	Mnu3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUnoXmc5UUN3ME2xOlYvPjFibl2=	MmXoV2FPT0WU
BV-173	NEf2NodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVL5W5hKUUN3ME2xPFYvPTVibl2=	M3ruUXNCVkeHUh?=
LB2241-RCC	M3rrXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NELI[GNKSzVyPUG5OE46OyCwTR?=	NV3Hco8zW0GQR1XS
KG-1	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXjRVnBzUUN3ME2yNFQvOzRibl2=	NI\ORpZUSU6JRWK=
CHL-1	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M{P0dWlEPTB;MkC4MlUyKG6P	MoTjV2FPT0WU
KYSE-140	NEPmb49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVHkV4gzUUN3ME2yNFkvQTZibl2=	NGHEPWRUSU6JRWK=
DU-145	NEDTZ3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NV:2U\|d2UUN3ME2yNVkvODRibl2=	NVTwR2dzW0GQR1XS
EW-13	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4LSTmlEPTB;MkK1MlEhdk1?	MkPIV2FPT0WU
KYSE-450	M2HsXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MUnJR\|UxRTJ2Nz65NkBvVQ>?	NH7qdGxUSU6JRWK=
CAL-72	NIfFWJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4i2NGlEPTB;Mk[4Mlc{KG6P	MmnFV2FPT0WU
MEG-01	M1K2Omdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MYXJR\|UxRTJ5Nj63OkBvVQ>?	MkO2V2FPT0WU
HCE-T	M2raTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NF3COGtKSzVyPUK3PU44QSCwTR?=	NXXjWGk6W0GQR1XS
NCI-SNU-1	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkHzTWM2OD1{OEOuN\|Ihdk1?	M1XPO3NCVkeHUh?=
CAL-27	M2\qcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYjp[nFjUUN3ME2yPFkvODhibl2=	NWXZWW1RW0GQR1XS
BALL-1	NYjOdmR4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWjJR\|UxRTJ7Nz60NkBvVQ>?	NFzj[YRUSU6JRWK=
SBC-1	Mlv3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXXJR\|UxRTNyNz63PUBvVQ>?	NIXiU4NUSU6JRWK=
CAL-54	NWnoVoN7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYPoUJhvUUN3ME2zNVEvOjNibl2=	MVTTRW5ITVJ?
TI-73	M{fHZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVXGbmYyUUN3ME2zNVIvPzVibl2=	M3z3THNCVkeHUh?=
P12-ICHIKAWA	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWrJR\|UxRTN{OD6wOkBvVQ>?	NWnnWYh4W0GQR1XS
ACHN	M4f4TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NUjNNJA6UUN3ME2zN\|EvPCCwTR?=	NWTYUmc1W0GQR1XS
PC-14	MlTjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NImzXmpKSzVyPUOzN{41OSCwTR?=	M2XCXHNCVkeHUh?=
HCC1806	MlnrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3LtTGlEPTB;M{O3MlUyKG6P	MWrTRW5ITVJ?
SK-MEL-24	MmWwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVfJR\|UxRTN\|Nz64O{BvVQ>?	NU\6SXhtW0GQR1XS
A4-Fuk	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVHDWGdiUUN3ME2zOVAvODJibl2=	MV7TRW5ITVJ?
ECC10	MkP0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUXo[XFEUUN3ME2zOVIvQTZibl2=	MUXTRW5ITVJ?
KASUMI-1	NHXYSIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MofqTWM2OD1\|Nk[uO\|Mhdk1?	NGTZOnJUSU6JRWK=
CAL-33	NH7aUHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYjJR\|UxRTN5MD65JI5O	NH;ucIdUSU6JRWK=
MDA-MB-175-VII	MnrzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYHJR\|UxRTN5OD64PEBvVQ>?	M2PZUnNCVkeHUh?=
NUGC-3	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3WzOGlEPTB;NECxMlgyKG6P	NH;1dodUSU6JRWK=
KY821	MoSzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MknLTWM2OD12MEiuOVchdk1?	NXn0WJZzW0GQR1XS
CTB-1	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1f6SGlEPTB;NEK0MlQhdk1?	NHjuW3NUSU6JRWK=
DoTc2-4510	NV7rfFBGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYXt[HJRUUN3ME20OFIvOTJibl2=	NUTkcnVwW0GQR1XS
EFO-27	M2Dv[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHfLfFVKSzVyPUS1OE44PCCwTR?=	NWrQcXpWW0GQR1XS
BPH-1	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3rrOWlEPTB;NEmxMlE3KG6P	NWfyUGxjW0GQR1XS
KYSE-270	Mm\DS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MofBTWM2OD12OUiuOlUhdk1?	MVrTRW5ITVJ?
HO-1-N-1	NVqyPJR1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWDJR\|UxRTVyOT6yOUBvVQ>?	MmTCV2FPT0WU
SK-MEL-1	M{T3WWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXv2e4dlUUN3ME21NVAvQTlibl2=	NEK2RVlUSU6JRWK=
MOLT-13	M37lfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NID4WlhKSzVyPUWxOE45OiCwTR?=	MVTTRW5ITVJ?
TK10	NXzUcGRFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWrFdIsxUUN3ME21NVUvOTFibl2=	NFzqNmFUSU6JRWK=
HN	NYjOSVVqT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MlPNTWM2OD13MUeuN\|ghdk1?	M4PQSXNCVkeHUh?=
SCC-15	NEHaVFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYWxcZVOUUN3ME21NlUvPjhibl2=	NHHhS4JUSU6JRWK=
NCI-H358	M1HZ[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVnkRWgyUUN3ME21NlcvPjZibl2=	NH;ReJNUSU6JRWK=
KYSE-180	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWnJR\|UxRTV\|MD62NkBvVQ>?	M3e4UXNCVkeHUh?=
NCI-H82	M1qwZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MkPNTWM2OD13NECuOUBvVQ>?	NXfTWIJ{W0GQR1XS
NB7	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXfJR\|UxRTV2Nj6zNkBvVQ>?	MkX5V2FPT0WU
DSH1	NF;JZ\|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFvnd2VKSzVyPUW2Ok45QCCwTR?=	MV3TRW5ITVJ?
RS4-11	M2fEXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MknhTWM2OD13NkiuOVkhdk1?	Mne3V2FPT0WU
CAN	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVTzNIlJUUN3ME21PFAvPzZibl2=	MXHTRW5ITVJ?
Ca9-22	M2fZWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Ml2xTWM2OD13OEiuOlQhdk1?	M{HNdHNCVkeHUh?=
CAL-39	Mn\kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mk\DTWM2OD13OU[uN{BvVQ>?	MYTTRW5ITVJ?
NCI-H1623	NV7uWHZXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXjJR\|UxRTV7OT6zOkBvVQ>?	MV7TRW5ITVJ?
FADU	MlrRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXrJR\|UxRTZyND62PUBvVQ>?	MUnTRW5ITVJ?
NB69	MonsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MoKyTWM2OD14MUSuN\|Uhdk1?	MkGzV2FPT0WU
Ramos-2G6-4C10	NUi5W3BxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFfheHNKSzVyPU[yNU41PiCwTR?=	Mm\xV2FPT0WU
LB1047-RCC	M1PHe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MonWTWM2OD14MkWuNlkhdk1?	NV\Fc5h2W0GQR1XS
MV-4-11	M1LQSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1nSdWlEPTB;NkK3Mlchdk1?	NUfiPYhpW0GQR1XS
DBTRG-05MG	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NEPBWZhKSzVyPU[zNk4zQCCwTR?=	NFu2WlFUSU6JRWK=
ME-180	Ml\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M17rWGlEPTB;NkOyMlkhdk1?	NFjV[HBUSU6JRWK=
NBsusSR	MluzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUDaXFh3UUN3ME22OFYvPTJibl2=	MUPTRW5ITVJ?
COR-L105	NYrW[G5QT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NY\xTWdpUUN3ME22OlIvPTNibl2=	NIr1UZpUSU6JRWK=
ETK-1	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnnHTWM2OD14NkKuOVkhdk1?	M1racXNCVkeHUh?=
L-363	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MUHJR\|UxRTZ5MT65OEBvVQ>?	MWHTRW5ITVJ?
LU-134-A	NXjw[VZyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1r0RmlEPTB;N{G5MlA6KG6P	NWKye4tOW0GQR1XS
NCI-H1770	NF:0U4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYnlT5dwUUN3ME23NlIvPCCwTR?=	MXfTRW5ITVJ?
HAL-01	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWPWOXhwUUN3ME23N\|QvPzFibl2=	NF\5UpBUSU6JRWK=
COLO-684	NXnoSYx3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NUS2Wo9wUUN3ME23OVMvODFibl2=	NVLuXXA2W0GQR1XS
TE-6	M3HxU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGGyXIVKSzVyPUe2OE4{OSCwTR?=	MojmV2FPT0WU
A431	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYHJR\|UxRTd6MD6wOEBvVQ>?	MX;TRW5ITVJ?
LU-135	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Ml\rTWM2OD15OEOuNFMhdk1?	NGrh[3dUSU6JRWK=
EC-GI-10	Mo\JS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2HZ[GlEPTB;N{i4MlUzKG6P	NELYXZlUSU6JRWK=
TE-12	MmLXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVzJR\|UxRTh{MT6xNUBvVQ>?	MoPzV2FPT0WU
LoVo	NVq0d5lRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWHRNW1wUUN3ME24OVkvODZibl2=	NHi0cVFUSU6JRWK=
23132-87	NEDyW5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2XJO2lEPTB;OE[0MlI5KG6P	NUTQXIMzW0GQR1XS
AU565	NWrieHdvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MV\JR\|UxRTh4OT62JI5O	NGfCVGVUSU6JRWK=
DEL	NUnBfFhET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MmX6TWM2OD16N{euOlUhdk1?	NFzvO4xUSU6JRWK=
COR-L88	NF\0cWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUfidVhZUUN3ME24PFIvOjZibl2=	MnPiV2FPT0WU
NCI-H2126	MkLnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkjGTWM2OD16OEKuPFMhdk1?	NGDPTlNUSU6JRWK=
CAPAN-1	NWfySnRDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Ml:5TWM2OD16OEOuNlkhdk1?	Ml74V2FPT0WU
BT-474	NYPH[mNXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NUnxSXk{UUN3ME25N\|gvOTRibl2=	MV\TRW5ITVJ?
BHY	NIjYeZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUWyTJNFUUN3ME25O\|UvPDhibl2=	NX76bIp6W0GQR1XS
HT-3	NUDscIUxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2\tVmlEPTB;OUiyMlQyKG6P	M{PUU3NCVkeHUh?=
SK-NEP-1	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVX4OYpYUUN3ME25PFkvPDRibl2=	NGjh[IlUSU6JRWK=
MS-1	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnTmTWM2OD17OUSuOlkhdk1?	MXLTRW5ITVJ?
DOHH-2	M{LGUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXHJR\|UxRTFwMECwNlEh\|ryP	NUDHWJRwW0GQR1XS
NCI-H1304	NGHZUppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4j1U2lEPTB;MT6wNVY1OyEQvF2=	MU\TRW5ITVJ?
EM-2	NF6wZWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1vtbWlEPTB;MT6wN\|AyPiEQvF2=	MVHTRW5ITVJ?
MHH-PREB-1	NGTM[2pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYjNcYFXUUN3ME2xMlA5PDVzIN88US=>	M2H0dXNCVkeHUh?=
KU-19-19	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWfJR\|UxRTFwMEi1OFEh\|ryP	NH;0T5NUSU6JRWK=
NCI-H1648	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVTwdXRGUUN3ME2xMlExPjF4IN88US=>	NHzZfnNUSU6JRWK=
MKN1	M1XMUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NF;KRppKSzVyPUGuNlE6QDdizszN	NWPETWZlW0GQR1XS
SNU-449	MmjhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkLPTWM2OD1zLkKyNlA5KM7:TR?=	MYjTRW5ITVJ?
OAW-42	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M{HIO2lEPTB;MT6yO\|gzPSEQvF2=	MUPTRW5ITVJ?
769-P	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NV3vdoV2UUN3ME2xMlI4QTF6IN88US=>	NWGxVFZsW0GQR1XS
SW1088	MlyxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1H0bWlEPTB;MT6yPVYxPyEQvF2=	MoXCV2FPT0WU
GCIY	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmfvTWM2OD1zLkOwNVMzKM7:TR?=	NH7KPFVUSU6JRWK=
CTV-1	MmnVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYfJR\|UxRTFwM{C4JO69VQ>?	NELTPJhUSU6JRWK=
NCI-H1092	NHq3bIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MlHVTWM2OD1zLkOwPFUh\|ryP	M4mzXXNCVkeHUh?=
NKM-1	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MUfJR\|UxRTFwM{K1PVch\|ryP	NGnHRWpUSU6JRWK=
NCI-H1650	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkLGTWM2OD1zLkOzOFgzKM7:TR?=	NWO4Tm13W0GQR1XS
SW954	M3[wNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MoXYTWM2OD1zLkO0NFQ5KM7:TR?=	Mn[2V2FPT0WU
SW48	NV;2XG9QT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXrjdpRjUUN3ME2xMlM3PjF6IN88US=>	NXnn[VY6W0GQR1XS
SK-N-DZ	MmD5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkHkTWM2OD1zLkO2PVQ4KM7:TR?=	M3\ZNnNCVkeHUh?=
KMOE-2	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MljaTWM2OD1zLkO5PFE2KM7:TR?=	NFvnN2JUSU6JRWK=
NB5	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NX[wPYVXUUN3ME2xMlQxQDl2IN88US=>	MY\TRW5ITVJ?
CCRF-CEM	M3TUS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVfpbXc3UUN3ME2xMlQyOTFizszN	MYHTRW5ITVJ?
RH-1	MknaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1L2ZWlEPTB;MT60NVE{PiEQvF2=	NWrXRohyW0GQR1XS
NCI-H526	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mn3ETWM2OD1zLkSzPFI3KM7:TR?=	NILq[IhUSU6JRWK=
697	NIfkTmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{PDZmlEPTB;MT60OFExPCEQvF2=	MVHTRW5ITVJ?
J82	MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVvJR\|UxRTFwNEW3OlYh\|ryP	NE\IdFNUSU6JRWK=
BE-13	MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NF7qdFJKSzVyPUGuOVA3PzFizszN	NXX0[IZHW0GQR1XS
SAS	MmfKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHLmeFBKSzVyPUGuOVE3OjJizszN	M4L1dHNCVkeHUh?=
SCC-25	NIHHNZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MkKxTWM2OD1zLkWyN\|IzKM7:TR?=	NYnlTm43W0GQR1XS
LAMA-84	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mm\UTWM2OD1zLkWzPFE2KM7:TR?=	NUXXUZRnW0GQR1XS
HSC-3	NE\VfJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGfPU5RKSzVyPUGuOVQ{QCEQvF2=	NETEN45USU6JRWK=
BT-549	NIri[JhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGnrbHpKSzVyPUGuOVg4PDdizszN	NXf1U3g6W0GQR1XS
ML-2	M{TQbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3q2bWlEPTB;MT62OFAzQSEQvF2=	M2X1OnNCVkeHUh?=
BB30-HNC	NGrjXZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{PNbGlEPTB;MT62PFk4OiEQvF2=	NF3xeVFUSU6JRWK=
PANC-03-27	MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M{fHc2lEPTB;MT63NFE{QSEQvF2=	MYPTRW5ITVJ?
COLO-678	NVTEcGpPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NV7H[YZPUUN3ME2xMlc{PDR2IN88US=>	MXnTRW5ITVJ?
NCI-H1666	Ml:3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2LhNGlEPTB;MT63OFcxPCEQvF2=	MUXTRW5ITVJ?
NCI-H209	NIWw[nhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnHBTWM2OD1zLke3NlY6KM7:TR?=	MXfTRW5ITVJ?
EPLC-272H	NEDMUppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGe4WFBKSzVyPUGuPFU2PDlizszN	M3vafXNCVkeHUh?=
OMC-1	Mkf5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEXp[GJKSzVyPUGuPVk5QDhizszN	NYH2XFE6W0GQR1XS
HCC70	M33nOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MX\JR\|UxRTJwMEC4NVUh\|ryP	NGjtUoVUSU6JRWK=
CAL-12T	NE\DdnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{fwW2lEPTB;Mj6wNVg3OSEQvF2=	M1:4b3NCVkeHUh?=
TGBC24TKB	Mlr1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWHJR\|UxRTJwMEK5OlEh\|ryP	M4mzcnNCVkeHUh?=
EKVX	M4HLOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlfDTWM2OD1{LkC0PVM6KM7:TR?=	MUTTRW5ITVJ?
SW1116	MorLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NU\VU4VlUUN3ME2yMlA3ODB7IN88US=>	M173PHNCVkeHUh?=
NCI-H2009	MmTlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mke0TWM2OD1{LkC2NlE1KM7:TR?=	Mmf0V2FPT0WU
RPMI-8866	M{Tj[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Ml7MTWM2OD1{LkC4OFgyKM7:TR?=	NVTMUIFqW0GQR1XS
KARPAS-45	MnvHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEniZmFKSzVyPUKuNVI1PzlizszN	MnLYV2FPT0WU
RXF393	NVHJdVZyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NEnLZ4ZKSzVyPUKuNVMxOzZizszN	NFPaVYtUSU6JRWK=
786-0	NXrMS\|JsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MlTVTWM2OD1{LkG4OFA3KM7:TR?=	M1vEe3NCVkeHUh?=
SCC-4	NFPlVnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1TI[2lEPTB;Mj6yNVc4PiEQvF2=	MXPTRW5ITVJ?
BT-20	NH;TV3dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NG\GfohKSzVyPUKuNlY4PDRizszN	MmPzV2FPT0WU
A498	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkDQTWM2OD1{LkK5OFE2KM7:TR?=	MnL0V2FPT0WU
IGROV-1	NG\JNZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnfzTWM2OD1{LkOxNlM4KM7:TR?=	MV7TRW5ITVJ?
JVM-3	NIHaVYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVjJR\|UxRTJwM{S2OFMh\|ryP	MVfTRW5ITVJ?
NCI-H2170	M2nCS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGf6N\|ZKSzVyPUKuN\|Q4QDNizszN	M3rUd3NCVkeHUh?=
EW-18	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NE\k[HdKSzVyPUKuN\|U1PzFizszN	NWrkd\|NHW0GQR1XS
KU812	Mle5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MknlTWM2OD1{LkO2O\|c6KM7:TR?=	NU[wUXo5W0GQR1XS
NY	NIS5b5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MkXNTWM2OD1{LkO3Nlch\|ryP	NGfCb5dUSU6JRWK=
HTC-C3	NFnyW5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUXCNYw3UUN3ME2yMlQzOjZ5IN88US=>	NXfQZpQ6W0GQR1XS
CFPAC-1	Mn3vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnG5TWM2OD1{LkSzPFY1KM7:TR?=	NV7DfpU1W0GQR1XS
HH	NEfUSY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYnTXWdPUUN3ME2yMlQ6QDV2IN88US=>	M1rBZnNCVkeHUh?=
MKN7	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3vjSGlEPTB;Mj62Nlc1QCEQvF2=	NFrZbYZUSU6JRWK=
TE-8	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M17TTmlEPTB;Mj62N\|Y2OyEQvF2=	M{C4Z3NCVkeHUh?=
MC-IXC	MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXjWb4ppUUN3ME2yMlY1PDV\|IN88US=>	NHTRV\|NUSU6JRWK=
DMS-79	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkTWTWM2OD1{Lk[5Nlg1KM7:TR?=	M1HU[nNCVkeHUh?=
Detroit562	NHjJ[XhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXPnZohmUUN3ME2yMlY6QDR3IN88US=>	NELleXpUSU6JRWK=
HuP-T4	M13zOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlX0TWM2OD1{LkeyPFE5KM7:TR?=	NI\SR4RUSU6JRWK=
QIMR-WIL	M2rWW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Ml;OTWM2OD1{Lke1PVUzKM7:TR?=	NUS3UoNtW0GQR1XS
BB65-RCC	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3[1cWlEPTB;Mj64NFcyOyEQvF2=	MV\TRW5ITVJ?
PC-3	MlPmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4H0WGlEPTB;Mj64N\|MyPyEQvF2=	MW\TRW5ITVJ?
OVCAR-3	NGXadphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUHJR\|UxRTJwOEW1PVQh\|ryP	Ml3aV2FPT0WU
KYSE-510	MkDRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGD2WnRKSzVyPUKuPFY4QDZizszN	Mlm3V2FPT0WU
HC-1	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkXPTWM2OD1{Lkm0NFEzKM7:TR?=	Mn;RV2FPT0WU
NCI-H1693	NEn5RXNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVzJR\|UxRTJwOUW4PVch\|ryP	M1rRUnNCVkeHUh?=
DU-4475	M4fyemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MoTvTWM2OD1{Lkm5NFUzKM7:TR?=	NWn4OGZGW0GQR1XS
COLO-680N	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2LIOmlEPTB;Mz6wNFQ6PSEQvF2=	MnrnV2FPT0WU
MN-60	NX3zW2RwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3fOWmlEPTB;Mz6wOFk4PCEQvF2=	MYjTRW5ITVJ?
BCPAP	NGPlTplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MX7JR\|UxRTNwMEiyPVUh\|ryP	NIrBeFNUSU6JRWK=
647-V	MlXMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXvRSY14UUN3ME2zMlE3OjJizszN	MUnTRW5ITVJ?
HT-1376	NE[wfYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWXJR\|UxRTNwMkC1NFYh\|ryP	NIn5e2xUSU6JRWK=
NCI-H1793	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MUPJR\|UxRTNwMkGwPVgh\|ryP	MVnTRW5ITVJ?
SW1463	NHnFeYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NX\zUosxUUN3ME2zMlI3OTl{IN88US=>	M2fGNXNCVkeHUh?=
NCI-H727	NG\aZXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M17JdmlEPTB;Mz6zPFU5PCEQvF2=	NH\ucXJUSU6JRWK=
LB771-HNC	NGXpeIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYXH[4JXUUN3ME2zMlM6OTJ4IN88US=>	NWPvcpFKW0GQR1XS
D-542MG	M4\WNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1fDTWlEPTB;Mz60OFIzOiEQvF2=	MYTTRW5ITVJ?
NTERA-S-cl-D1	M3HzOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NUPldGhGUUN3ME2zMlQ1QTV5IN88US=>	NILVNpdUSU6JRWK=
C8166	NIHvZ2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2ThNWlEPTB;Mz60OlUzOSEQvF2=	MVvTRW5ITVJ?
639-V	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M16ybWlEPTB;Mz61O\|c6OiEQvF2=	NHnvWIZUSU6JRWK=
TE-1	NHjRcVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVvJR\|UxRTNwNUmxOlkh\|ryP	NEDOU4tUSU6JRWK=
OAW-28	MmjjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVrJR\|UxRTNwNUm0NlYh\|ryP	M2KwXnNCVkeHUh?=
SK-LU-1	NEPRb2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYDJR\|UxRTNwNkC2OFUh\|ryP	MojyV2FPT0WU
CaR-1	MlSxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEDDOm5KSzVyPUOuOlExPDhizszN	NGXabXFUSU6JRWK=
A2780	M3jxXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXjidnJQUUN3ME2zMlY1ODh7IN88US=>	MlvhV2FPT0WU
C2BBe1	NHnpdHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXvnOVNrUUN3ME2zMlY1PDB5IN88US=>	M{LINnNCVkeHUh?=
SK-MES-1	NXTXTlBlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2rPR2lEPTB;Mz62OFYyPCEQvF2=	Ml3UV2FPT0WU
PANC-10-05	NVX5N4tnT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2q0SmlEPTB;Mz63NlA4OiEQvF2=	NGTOco1USU6JRWK=
J-RT3-T3-5	NWn4fGJUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NY\YNVRPUUN3ME2zMlc2PDB4IN88US=>	M3;Fb3NCVkeHUh?=
ES4	MmjUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYrJR\|UxRTNwOEKyPFYh\|ryP	NEfwZXFUSU6JRWK=
NCI-H28	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1vwNWlEPTB;Mz64Nlk3OSEQvF2=	M1jIVXNCVkeHUh?=
NCI-H1155	NUW0Z4xYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHvxfpFKSzVyPUOuPFQyPTlizszN	NIHLUZJUSU6JRWK=
KURAMOCHI	M1PoR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NH3neo5KSzVyPUOuPFYxPTZizszN	NU\mNFI2W0GQR1XS
NCI-H69	NXrsUmF[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1TkWGlEPTB;Mz65NFE4QCEQvF2=	MX\TRW5ITVJ?
IST-MES1	NGXpVXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXPJR\|UxRTNwOUSwNlkh\|ryP	M4\zS3NCVkeHUh?=
NH-12	M1;VZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MkHETWM2OD1\|Lkm0NVg4KM7:TR?=	Mnn1V2FPT0WU
JVM-2	Mm\WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mn\kTWM2OD1\|Lkm0O\|UzKM7:TR?=	MnPkV2FPT0WU
EW-16	NWXuTYd1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mlj2TWM2OD1\|Lkm1OVc4KM7:TR?=	NIjBOoNUSU6JRWK=
NCI-H441	MnjhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGLUeHpKSzVyPUOuPVcxOTRizszN	NYrOWG5SW0GQR1XS
RCC10RGB	NWXNbJR[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1TkPWlEPTB;ND6wNVI1PiEQvF2=	NXXQUpNOW0GQR1XS
TCCSUP	M{PwWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3nmfGlEPTB;ND6xNVA2KM7:TR?=	MWLTRW5ITVJ?
HL-60	M1nQWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1fSPGlEPTB;ND6xNlI1OSEQvF2=	NHL3bHhUSU6JRWK=
EW-11	NGTlSGNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MmrPTWM2OD12LkGzNlYyKM7:TR?=	Mnm4V2FPT0WU
KARPAS-299	M3rxc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MoizTWM2OD12LkOxNFE{KM7:TR?=	Mk\JV2FPT0WU
SNU-C2B	NIHmcWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWHubWpvUUN3ME20MlM1Pjh4IN88US=>	MVzTRW5ITVJ?
LU-139	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mki3TWM2OD12LkO3NlQ4KM7:TR?=	NY\4PYZUW0GQR1XS
HCC1937	M4jjbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnnVTWM2OD12LkO3PVk{KM7:TR?=	MU\TRW5ITVJ?
GR-ST	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MULJR\|UxRTRwNEOxPEDPxE1?	MlvWV2FPT0WU
SK-OV-3	MmGyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MlHZTWM2OD12LkS2NFQzKM7:TR?=	MYXTRW5ITVJ?
A172	MojJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1m2OmlEPTB;ND61OVUzOSEQvF2=	MX;TRW5ITVJ?
NB10	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2\XdmlEPTB;ND61PVc5OSEQvF2=	NW\ndGZsW0GQR1XS
P30-OHK	Ml[3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4nEUmlEPTB;ND64NVkzQSEQvF2=	M130OHNCVkeHUh?=
KYSE-520	NXzOUWFwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVHJR\|UxRTRwOEiwNVgh\|ryP	NGG5cXVUSU6JRWK=
KNS-62	MlLhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWTXXZZ5UUN3ME20MlkxQDB5IN88US=>	MV;TRW5ITVJ?
ES1	NELXboNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MX3JR\|UxRTRwOU[wN\|Uh\|ryP	MkX6V2FPT0WU
KOSC-2	Mly0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXjJR\|UxRTRwOUm5OVkh\|ryP	MUXTRW5ITVJ?
TE-9	M2nRRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXnJR\|UxRTVwMEG1NlUh\|ryP	MnewV2FPT0WU
NCI-H1838	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4jJT2lEPTB;NT6wNlA4PiEQvF2=	MV;TRW5ITVJ?
KP-N-YN	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NUjveJc5UUN3ME21MlEzPTlzIN88US=>	NFTnXnJUSU6JRWK=
ALL-PO	Mlr3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4[0VmlEPTB;NT6yNlU5PyEQvF2=	MYrTRW5ITVJ?
NOMO-1	NIjyOoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4ewW2lEPTB;NT6yN\|E4PiEQvF2=	M2q2dnNCVkeHUh?=
CGTH-W-1	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXvJR\|UxRTVwM{i1PFQh\|ryP	MVzTRW5ITVJ?
ATN-1	NWjn[\|FYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHWzVVhKSzVyPUWuOFEyQDRizszN	NEnVRopUSU6JRWK=
AGS	MkDVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NELKXmtKSzVyPUWuOFk3OThizszN	M32zNHNCVkeHUh?=
SW13	M1Oz[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWfJR\|UxRTVwNUOyOlUh\|ryP	NVXS[HJMW0GQR1XS
SW1990	NIjKTZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NE\FfnNKSzVyPUWuOlIzQDVizszN	MXvTRW5ITVJ?
BFTC-905	M4DDU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVmzWXREUUN3ME21MlY2QDd6IN88US=>	NXrLU3FjW0GQR1XS
RMG-I	NYfHZVl4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWPJR\|UxRTVwNkW5OFIh\|ryP	M3LCV3NCVkeHUh?=
HD-MY-Z	M1v4ZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVTST5c6UUN3ME21MlY5PThzIN88US=>	MlPZV2FPT0WU
HCC1187	NETyVFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFrMXGhKSzVyPUWuO\|ExOzJizszN	NGTac49USU6JRWK=
HCC2998	Mn;oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mn;tTWM2OD13LkexPFc4KM7:TR?=	NYWySIp7W0GQR1XS
RT-112	NF7TOXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1vpbWlEPTB;NT65NFI1PSEQvF2=	M3m0dXNCVkeHUh?=
CAKI-1	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NInNNnlKSzVyPU[uNFA6QDVizszN	MWfTRW5ITVJ?
HDLM-2	NVXWTY5VT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mk\yTWM2OD14LkCxOFg6KM7:TR?=	MkOwV2FPT0WU
TE-10	M33EWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4Lt[GlEPTB;Nj6wOFg{OyEQvF2=	NFew[ppUSU6JRWK=
KE-37	M1jxOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmnYTWM2OD14LkC3NlU5KM7:TR?=	MX7TRW5ITVJ?
RCM-1	NIjWNZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoLaTWM2OD14LkC3O\|E6KM7:TR?=	MmW2V2FPT0WU
Mewo	MknrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mn\aTWM2OD14LkGxOFg4KM7:TR?=	MnG2V2FPT0WU
L-428	NEOyWHJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MljlTWM2OD14LkG4NFM4KM7:TR?=	MXfTRW5ITVJ?
8-MG-BA	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGLafINKSzVyPU[uNVk{PzlizszN	M{W2U3NCVkeHUh?=
SK-MEL-28	NUfYUJU{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXPJR\|UxRTZwMkC5Olch\|ryP	NFzJZm1USU6JRWK=
VA-ES-BJ	NWTvdY9xT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NH71eJpKSzVyPU[uN\|A1PjJizszN	NEjxe\|ZUSU6JRWK=
CAL-120	MkXyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4TuW2lEPTB;Nj60OVE3OiEQvF2=	M4TteHNCVkeHUh?=
GAMG	NWG5SnA2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MoLYTWM2OD14LkWwOlIh\|ryP	M2X2eXNCVkeHUh?=
MSTO-221H	NGLtbodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUTsRYQ4UUN3ME22MlUyOTdizszN	MlHOV2FPT0WU
GCT	NYDnSZhCT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4WydGlEPTB;Nj61N\|M5PyEQvF2=	MWHTRW5ITVJ?
SH-4	M3n2eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFHicpBKSzVyPU[uOVg5PDRizszN	M3TlfXNCVkeHUh?=
Calu-3	MmLOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M33YUWlEPTB;Nj62OVU3QCEQvF2=	M1rR[3NCVkeHUh?=
SK-HEP-1	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHT0VItKSzVyPU[uO\|E4PTNizszN	M2rPfXNCVkeHUh?=
PFSK-1	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2XLeWlEPTB;Nj63N\|Q4QCEQvF2=	NIn2eXRUSU6JRWK=
NB12	NUi4W3JlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYnPdZFIUUN3ME22Mlc5PDB2IN88US=>	MXfTRW5ITVJ?
A388	NI\TdGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1G5OmlEPTB;Nj64PVUzKM7:TR?=	MWXTRW5ITVJ?
KLE	Mke5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mn64TWM2OD14Lkm2OVE3KM7:TR?=	NUS3bnVkW0GQR1XS
TE-11	NYr6cZhHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MkewTWM2OD15LkC0PVY4KM7:TR?=	NVey[JNLW0GQR1XS
NCI-H2405	MoXPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVXJR\|UxRTdwMEizPVMh\|ryP	NVPaTXFSW0GQR1XS
OVCAR-4	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4noU2lEPTB;Nz6xOVM2KM7:TR?=	NXHnbFBSW0GQR1XS
KP-N-YS	M4DqfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmGzTWM2OD15LkG4NVQh\|ryP	MUPTRW5ITVJ?
NOS-1	M1HCO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1TOSWlEPTB;Nz6yOVgzQCEQvF2=	MYnTRW5ITVJ?
DMS-114	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1r4WGlEPTB;Nz6yPVY{OSEQvF2=	MYHTRW5ITVJ?
NCI-H2030	M1\ncGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NUnkRoM1UUN3ME23MlM{Pjl6IN88US=>	MnvKV2FPT0WU
HEL	NFy4RldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFXtZZNKSzVyPUeuN\|c2OjFizszN	NEXUT\|VUSU6JRWK=
CAL-62	NIX5OVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NF2xOJBKSzVyPUeuN\|k5PjZizszN	MoXxV2FPT0WU
COLO-668	Mo[2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NH\wflVKSzVyPUeuOFM6PjdizszN	MULTRW5ITVJ?
SKG-IIIa	MoHuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXfPfHZZUUN3ME23MlQ2OzhzIN88US=>	NWnQcVZxW0GQR1XS
HCC1419	MljZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEjuNJBKSzVyPUeuOFY5OzNizszN	NE[1SYpUSU6JRWK=
OS-RC-2	NIPkcZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4SzTWlEPTB;Nz60PVg6PCEQvF2=	MUXTRW5ITVJ?
COLO-829	M{G2NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGPJbXdKSzVyPUeuOlY1PjNizszN	NV;sfnBFW0GQR1XS
NB13	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkTyTWM2OD15LkiyOlY4KM7:TR?=	MYTTRW5ITVJ?
DK-MG	Mn;uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MX3JR\|UxRTdwOEOyNFEh\|ryP	Mlq0V2FPT0WU
SHP-77	NIP2ZlJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NELmVIdKSzVyPUeuPFY3PTNizszN	MlPRV2FPT0WU
NCI-H661	NHP2bHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3jpcmlEPTB;OD6wOVg3PyEQvF2=	Mlz3V2FPT0WU
AM-38	NW\Zbo1GT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MnG3TWM2OD16LkG2Nlgh\|ryP	Mm[1V2FPT0WU
VM-CUB-1	M{\lUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnnyTWM2OD16LkG3NFI6KM7:TR?=	M1;MfXNCVkeHUh?=
KYSE-70	M2r4UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MUPJR\|UxRThwMUm3OlEh\|ryP	M2PHW3NCVkeHUh?=
5637	M37RVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnL3TWM2OD16LkOxNFU2KM7:TR?=	Moe1V2FPT0WU
TGBC11TKB	NUfkWpZLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1\sS2lEPTB;OD60OlE3PCEQvF2=	MoPZV2FPT0WU
EGI-1	M{\yVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHXoT25KSzVyPUiuOlAxQDhizszN	MXnTRW5ITVJ?
D-392MG	NG\R[2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnjWTWM2OD16Lk[2NlE1KM7:TR?=	NXLySW5SW0GQR1XS
A673	MlTOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVnZfmxkUUN3ME24MlY4PjFzIN88US=>	NUjq[4loW0GQR1XS
COLO-792	NH7aOYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUTJR\|UxRThwN{S5OFYh\|ryP	NHn2blRUSU6JRWK=
NCI-H1792	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWDJR\|UxRThwOEi5NFMh\|ryP	NHuw[YlUSU6JRWK=
LS-1034	NIfpcGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NI\DNIVKSzVyPUiuPVQ3PTJizszN	M{C4N3NCVkeHUh?=
D-566MG	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mn;OTWM2OD17LkCxPFEh\|ryP	MVnTRW5ITVJ?
NCI-H226	MnLlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWO3b\|FVUUN3ME25MlA6KM7:TR?=	MlzWV2FPT0WU
ChaGo-K-1	MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NX\2[IVkUUN3ME25MlExPTd7IN88US=>	M3G2XXNCVkeHUh?=
NCI-H2228	NUK5TpdJT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1XINmlEPTB;OT6xNVA5OSEQvF2=	MoLwV2FPT0WU
RPMI-8226	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXLJR\|UxRTlwMUGzNFQh\|ryP	NWTZVWNxW0GQR1XS
BFTC-909	NFz5XJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1KxZ2lEPTB;OT6xPFI6PyEQvF2=	NWrEPWFPW0GQR1XS
HPAF-II	MkT2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWHwN5k3UUN3ME25MlIzPTF6IN88US=>	M{jYVXNCVkeHUh?=
Capan-2	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NIfv[2FKSzVyPUmuOFAyODlizszN	MnPNV2FPT0WU
IA-LM	MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NEjYcoxKSzVyPUmuOFE6PjZizszN	M4fCT3NCVkeHUh?=
KP-4	NH7iRWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Mm\UTWM2OD17LkS4PFM5KM7:TR?=	M1L0VHNCVkeHUh?=
A101D	MkTZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEOw[GVKSzVyPUmuOVE4OTlizszN	NWHjVYZHW0GQR1XS
EFO-21	NHPQT2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2DkXmlEPTB;OT61PFc{PSEQvF2=	MnfjV2FPT0WU
C32	MkfwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2LHU2lEPTB;OT62N\|M1KM7:TR?=	MXTTRW5ITVJ?
SW837	M4fEOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXHJR\|UxRTlwOES4NkDPxE1?	Ml;jV2FPT0WU
OCI-AML2	NXnLXIZ{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYfDbXg6UUN3ME25Mlg3QTZizszN	MYLTRW5ITVJ?
NCI-H1355	NHXIV\|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXHBVphyUUN3ME25Mlk1ODh6IN88US=>	MnTLV2FPT0WU
NCI-H2342	NV\DUYpOT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWq1Zlg1UUN3ME2xNE4xOTV3IN88US=>	NFrwPVBUSU6JRWK=
A204	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlfuTWM2OD1zMD6wOFY3KM7:TR?=	Ml;aV2FPT0WU
CAL-51	M{DCb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGr1T2pKSzVyPUGwMlA5PzdizszN	NISySFlUSU6JRWK=
HCE-4	MlrJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2jyRWlEPTB;MUCuNVEzOiEQvF2=	M3PP[XNCVkeHUh?=
NCI-H810	NYraXnR2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M{HufmlEPTB;MUCuNVU6PyEQvF2=	NECxTnZUSU6JRWK=
DJM-1	MlPjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUnJR\|UxRTFyLkG3N\|Ih\|ryP	NEXqfnpUSU6JRWK=
SK-UT-1	NV;VcJhbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1;Yc2lEPTB;MUCuNlU4PCEQvF2=	NH3G[lFUSU6JRWK=
U031	NGrsfXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoPKTWM2OD1zMD6yOlg3KM7:TR?=	M16yOnNCVkeHUh?=
YH-13	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmOzTWM2OD1zMD6zNFU4KM7:TR?=	MmPaV2FPT0WU
K5	NEHINYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHzLR2xKSzVyPUGwMlM{QTVizszN	MnH1V2FPT0WU
HEC-1	Mn7OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXHJR\|UxRTFyLkSwPFEh\|ryP	NWWzTFhPW0GQR1XS
A2058	M1TMe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NH35fWVKSzVyPUGwMlU1QTFizszN	MVLTRW5ITVJ?
SW962	M3jvUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NEXxZoZKSzVyPUGwMlYzODRizszN	NGDDc4pUSU6JRWK=
VMRC-RCZ	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXSzUIJOUUN3ME2xNE43PzR7IN88US=>	MoPDV2FPT0WU
D-336MG	Mnv1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NYr3R4JUUUN3ME2xNE44ODB3IN88US=>	NEPaVWNUSU6JRWK=
LXF-289	NYXIeGVQT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NEDI[YJKSzVyPUGwMlc6PjdizszN	NXPlVow2W0GQR1XS
SW900	M37ZSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYfyWJU6UUN3ME2xNE45OjJ6IN88US=>	NI\w[XRUSU6JRWK=
K-562	Ml7ZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXjDSYE6UUN3ME2xNE45Ozl3IN88US=>	MlHtV2FPT0WU
HCC38	MlzxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEHWUVVKSzVyPUGwMlk4OTZizszN	NVrPU29YW0GQR1XS
SF-295	NVzsO5lOT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NY\5dZduUUN3ME2xNE46QTB{IN88US=>	MYDTRW5ITVJ?
LB831-BLC	Mo\pS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1fFWmlEPTB;MUGuNlU2PiEQvF2=	MUPTRW5ITVJ?
FTC-133	NXK1VpNiT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M{PsS2lEPTB;MUGuN\|A5OSEQvF2=	MXHTRW5ITVJ?
HCC1954	NVyzUmtHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2TNcWlEPTB;MUGuOFM3KM7:TR?=	NIHMU\|dUSU6JRWK=
GOTO	NYLheWxuT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4KwW2lEPTB;MUGuOVIxPiEQvF2=	MXzTRW5ITVJ?
LS-411N	NEfnNHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVLsNm1VUUN3ME2xNU43OTBzIN88US=>	MUDTRW5ITVJ?
RPMI-7951	NEjlcFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Mn;PTWM2OD1zMT62N\|Q5KM7:TR?=	MkLVV2FPT0WU
NCI-H1299	NYXtNZhwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NIHNV4NKSzVyPUGxMlY3PDdizszN	M2nMW3NCVkeHUh?=
MLMA	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1rYPWlEPTB;MUGuOlk6PyEQvF2=	MkC2V2FPT0WU
MMAC-SF	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWXJR\|UxRTFzLkeyOVIh\|ryP	NGLVVXVUSU6JRWK=
UM-UC-3	NWCweoVNT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M{S5XmlEPTB;MUGuO\|QzOSEQvF2=	NHTVT4NUSU6JRWK=
SCC-9	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVHJR\|UxRTFzLkixOVEh\|ryP	MWrTRW5ITVJ?
HOS	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Ml\mTWM2OD1zMT64Olg{KM7:TR?=	MYjTRW5ITVJ?
OE19	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MY\JR\|UxRTFzLkmzOlch\|ryP	NVrO[GF6W0GQR1XS
Mo-T	M1XaXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mo\WTWM2OD1zMT65OVQyKM7:TR?=	M1\0SnNCVkeHUh?=
CAMA-1	M2rXS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NEG5N\|ZKSzVyPUGyMlE3OzNizszN	NUjXb\|cyW0GQR1XS
U-118-MG	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHi2e2hKSzVyPUGyMlI1PDFizszN	M3O0c3NCVkeHUh?=
KS-1	NGjhOYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHPke2JKSzVyPUGyMlI5OzJizszN	NHOwOXJUSU6JRWK=
JAR	NGXubVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MX3JR\|UxRTF{LkOzOlkh\|ryP	MlfqV2FPT0WU
ABC-1	M4PBb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGPPPVhKSzVyPUGyMlM1OSEQvF2=	NWLtTI46W0GQR1XS
Daoy	NXi4eZZLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1uzT2lEPTB;MUKuOFU1OiEQvF2=	M3fSO3NCVkeHUh?=
C3A	MmKwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVvSclBoUUN3ME2xNk42Pzh3IN88US=>	M3zPTnNCVkeHUh?=
GT3TKB	NHfkR\|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFHvbYpKSzVyPUGyMlY{OjdizszN	NV3wdVhiW0GQR1XS
DMS-273	NUjVO2JrT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3fxXWlEPTB;MUKuPFY{OyEQvF2=	NFvHPVdUSU6JRWK=
G-361	M{nGbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlPFTWM2OD1zMj65NVI6KM7:TR?=	M3PHSXNCVkeHUh?=
RH-18	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWfpRY04UUN3ME2xN{4zQTZ{IN88US=>	NF3LUXJUSU6JRWK=
SN12C	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHzCbmpKSzVyPUGzMlM5ODhizszN	M{\BXHNCVkeHUh?=
NCI-H1993	M2nyUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWrJR\|UxRTF\|LkSyPFUh\|ryP	NXftPGtEW0GQR1XS
LOXIMVI	NV\oPWFyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3nKPWlEPTB;MUOuOlE2OSEQvF2=	MWXTRW5ITVJ?
SK-PN-DW	MkD5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MX;JR\|UxRTF\|Lki0Nlch\|ryP	NV[3dHpGW0GQR1XS
KALS-1	NEDpfnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4XQ[2lEPTB;MUOuPFUzPSEQvF2=	NET4PZdUSU6JRWK=
LAN-6	NE[xT5NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Mn7sTWM2OD1zND6yOVMh\|ryP	NXHsblBxW0GQR1XS
A549	MlL5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3jjeGlEPTB;MUSuOFcyOiEQvF2=	NW\jRoZuW0GQR1XS
RD	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mnq4TWM2OD1zND60PFE{KM7:TR?=	NYPHOWxDW0GQR1XS
TGBC1TKB	M{PaNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NEHObnVKSzVyPUG0MlY3OTVizszN	MXXTRW5ITVJ?
NCI-H630	MlzzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWXJR\|UxRTF2Lkm0Olch\|ryP	NFzWT4dUSU6JRWK=
MIA-PaCa-2	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NF[wN4pKSzVyPUG0Mlk3QSEQvF2=	NWLVOYlRW0GQR1XS
NCI-H1755	NUnPcWpoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MX3JR\|UxRTF2Lkm5OVMh\|ryP	MoXsV2FPT0WU
MOLT-4	NXLzU5hLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1TTb2lEPTB;MUWuNFQ6PyEQvF2=	NYHzUWs4W0GQR1XS
CW-2	MkmzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmOyTWM2OD1zNT6xOFIyKM7:TR?=	MmHoV2FPT0WU
COLO-320-HSR	MmDLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWTJR\|UxRTF3LkWzNFch\|ryP	M1PhXXNCVkeHUh?=
UMC-11	NUHQNYlsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mn7kTWM2OD1zNT63OVI{KM7:TR?=	MVnTRW5ITVJ?
MCF7	MoO0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYjJR\|UxRTF3LkixOFUh\|ryP	MmW5V2FPT0WU
NCI-H23	NUTleWhoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NUPCXpg1UUN3ME2xOU45PDN6IN88US=>	NXS5Z4c6W0GQR1XS
HuCCT1	NXj1WolTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1jYe2lEPTB;MUWuPFc1KM7:TR?=	NHj6fZJUSU6JRWK=
MPP-89	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2TYbmlEPTB;MUWuPVQyPyEQvF2=	NV;scIpVW0GQR1XS
HT55	NEfR[VdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXPJR\|UxRTF3Lkm0O\|gh\|ryP	NVrzcIZJW0GQR1XS
no-11	M3XSZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mn6yTWM2OD1zNT65OlY{KM7:TR?=	MW\TRW5ITVJ?
GP5d	NXnYNZl5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2i1T2lEPTB;MU[uNlE5PyEQvF2=	NH;uTXFUSU6JRWK=
BHT-101	M4qyb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MUTJR\|UxRTF4LkK0N\|kh\|ryP	M4nJUnNCVkeHUh?=
M059J	NIDkRmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoW4TWM2OD1zNj6yPFQh\|ryP	MWjTRW5ITVJ?
D-283MED	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHm5O3ZKSzVyPUG2MlQzODlizszN	NGe1SIRUSU6JRWK=
BEN	NFXz[\|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NF6xUYhKSzVyPUG2MlUyPTVizszN	NWLwR2NEW0GQR1XS
LB373-MEL-D	M{PFSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnPHTWM2OD1zNj63NlMzKM7:TR?=	NIf4PGpUSU6JRWK=
MEL-HO	Mm\1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEf6dldKSzVyPUG2Mlg5PTRizszN	NVfNN3piW0GQR1XS
GI-ME-N	NHrteHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUTJR\|UxRTF4LkmwN\|Ih\|ryP	Mmq3V2FPT0WU
RKO	NXG4[2ZyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFnWeY9KSzVyPUG3MlA4PDhizszN	NGHKcFNUSU6JRWK=
MZ2-MEL	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYDJR\|UxRTF5LkGzN{DPxE1?	NYDkNm1XW0GQR1XS
NCI-H1573	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYG0TnNmUUN3ME2xO{4zQDJ4IN88US=>	MU\TRW5ITVJ?
NCI-H1581	M4njN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NV\6RoZDUUN3ME2xO{41PDFzIN88US=>	MkPiV2FPT0WU
NCI-H747	M1jEbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3zhUGlEPTB;MUeuOVI6PyEQvF2=	M13ocnNCVkeHUh?=
SW1783	M3vP[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnnXTWM2OD1zNz62OFE2KM7:TR?=	Mn3CV2FPT0WU
Calu-6	NGjab3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYnJR\|UxRTF5Lk[3PFIh\|ryP	NEC2T4dUSU6JRWK=
SF268	Mo\qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGKwRpJKSzVyPUG3MlY6PjlizszN	NXXjWolYW0GQR1XS
ES8	MnrnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NY\wVY44UUN3ME2xO{45PTl\|IN88US=>	NX3vem9VW0GQR1XS
KM-H2	M1vadWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWfuR45CUUN3ME2xO{46PDFzIN88US=>	NHPYc4VUSU6JRWK=
D-502MG	M1HPV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NEfneYNKSzVyPUG3Mlk5ODhizszN	NEDTPG1USU6JRWK=
HLE	NX3uOFVpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NIDlXmRKSzVyPUG4MlMyPDhizszN	NHzKOnVUSU6JRWK=
SW982	NYnlOFRsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2PhSGlEPTB;MUiuOFA4PSEQvF2=	Ml7oV2FPT0WU
MDA-MB-361	NYDWSHYyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MnHBTWM2OD1zOD61OVg5KM7:TR?=	NWHoRog{W0GQR1XS
NCI-H1563	NXrHflRkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M{DGUWlEPTB;MUiuO\|EzPCEQvF2=	NE\QZpFUSU6JRWK=
MFE-280	MmDCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3H3N2lEPTB;MUiuO\|I6OyEQvF2=	M33pOHNCVkeHUh?=
U251	Ml;0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGDGOGtKSzVyPUG4Mlc{PDdizszN	MV3TRW5ITVJ?
KNS-42	NY[2O4dWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Ml[1TWM2OD1zOD64NFE2KM7:TR?=	M{P3PXNCVkeHUh?=
U-266	M4\N[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MkH0TWM2OD1zOD64OlQ6KM7:TR?=	MkDkV2FPT0WU
OVCAR-8	NGXYd3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWXxW2p5UUN3ME2xPE46Ojd4IN88US=>	NX3uNWZnW0GQR1XS
MFH-ino	M{ixOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2OzeWlEPTB;MUiuPVY3QSEQvF2=	NG[zcm5USU6JRWK=
D-263MG	M2DxVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NIDqc2VKSzVyPUG5MlAyPzJizszN	NXWyO4RoW0GQR1XS
NCI-H1437	Ml7WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHf2THhKSzVyPUG5MlA1PjdizszN	NYCybXFCW0GQR1XS
NCI-H1048	NFT5b4tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MkjqTWM2OD1zOT6yN\|I3KM7:TR?=	NFvsXXBUSU6JRWK=
NCI-H446	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmjCTWM2OD1zOT6zOVg6KM7:TR?=	M3rlXnNCVkeHUh?=
NCI-N87	M{fiN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmewTWM2OD1zOT61PVkzKM7:TR?=	NHTlZWZUSU6JRWK=
WM-115	MmXSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVnJR\|UxRTF7Lk[3O\|Qh\|ryP	NGGwdmdUSU6JRWK=
HuH-7	MmHUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MULJR\|UxRTF7Lke0NlEh\|ryP	NXLvbWd2W0GQR1XS
NCI-H650	MmPHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXjP[4dZUUN3ME2xPU44PTB6IN88US=>	NGS3TYNUSU6JRWK=
TYK-nu	NV[2dVBzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGLkfnFKSzVyPUG5Mlg{PzhizszN	NHTHWFJUSU6JRWK=
Becker	M3jndWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGrKXotKSzVyPUG5Mlg2PDdizszN	MUPTRW5ITVJ?
BB49-HNC	NUna[4N5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGPGcppKSzVyPUG5MlkzKM7:TR?=	NFPadYVUSU6JRWK=
HGC-27	NIm1O2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoGxTWM2OD1{MD6xN\|k1KM7:TR?=	M4ribXNCVkeHUh?=
SiHa	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnnZTWM2OD1{MD6zO\|EzKM7:TR?=	MkTvV2FPT0WU
LB2518-MEL	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWjJR\|UxRTJyLkO3N\|kh\|ryP	MnSwV2FPT0WU
TE-5	MkHZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mm\4TWM2OD1{MD63OFgzKM7:TR?=	NFrsOYFUSU6JRWK=
IST-SL1	MoPOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYDJR\|UxRTJyLke4O\|kh\|ryP	NFjkdnJUSU6JRWK=
A375	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M{f3W2lEPTB;MkGuNFU3PyEQvF2=	NHnub25USU6JRWK=
MC116	NYDISWFKT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4r0OGlEPTB;MkGuNFczOyEQvF2=	NWPMOGtGW0GQR1XS
GI-1	NI[1c\|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHHIeYlKSzVyPUKxMlE4KM7:TR?=	MmDCV2FPT0WU
HOP-62	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlPnTWM2OD1{MT6yO\|g1KM7:TR?=	MWfTRW5ITVJ?
PA-1	M{f0bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlLrTWM2OD1{MT6yO\|g4KM7:TR?=	MXvTRW5ITVJ?
HT	NGHuT2pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3PzR2lEPTB;MkGuOFM{OSEQvF2=	MkDKV2FPT0WU
HUTU-80	NYLUXGtET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXLC[HRHUUN3ME2yNU41OzN4IN88US=>	NXvveYg4W0GQR1XS
NCI-H1975	M3\tU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWjJR\|UxRTJzLkS2NUDPxE1?	NXzB[4E4W0GQR1XS
GAK	NUX5bI5JT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MULJR\|UxRTJzLkS5PUDPxE1?	M36xWnNCVkeHUh?=
SK-N-AS	Mn\lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEnZXY5KSzVyPUKxMlU3OTlizszN	MX3TRW5ITVJ?
OE33	Mn\RS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3zFW2lEPTB;MkGuOlA1PiEQvF2=	M{LoSHNCVkeHUh?=
YKG-1	MnPDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NFWwSm5KSzVyPUKxMlY2PDVizszN	MmP5V2FPT0WU
CAL-85	NFHtOZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NH\yR4hKSzVyPUKxMlk{ODVizszN	NIrhW4xUSU6JRWK=
NCI-H2347	NY\NSYFyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4Gwc2lEPTB;MkGuPVQzQCEQvF2=	MVPTRW5ITVJ?
PANC-08-13	Mmn3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1j3RWlEPTB;MkKuNFEyQSEQvF2=	M3rq[nNCVkeHUh?=
SK-N-FI	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4\IcmlEPTB;MkKuN\|A4PCEQvF2=	NETIdIpUSU6JRWK=
NEC8	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnywTWM2OD1{Mj61NFc5KM7:TR?=	NH[1cYxUSU6JRWK=
AN3-CA	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWfJR\|UxRTJ{Lk[wPFQh\|ryP	NH;1dlFUSU6JRWK=
HuO9	NXT2fHFzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXfmUmNsUUN3ME2yNk44Ozl4IN88US=>	MY\TRW5ITVJ?
COLO-800	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnHCTWM2OD1{Mj63OlU{KM7:TR?=	M{iwVHNCVkeHUh?=
HT-29	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M{iz[GlEPTB;MkKuPFgzOyEQvF2=	NFrRSmtUSU6JRWK=
OC-314	M1:wUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlzsTWM2OD1{Mj64PFQ2KM7:TR?=	MnjHV2FPT0WU
G-401	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXXJR\|UxRTJ\|LkC0OlIh\|ryP	NE[5XZhUSU6JRWK=
Saos-2	NX7XNWpxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGm1[HZKSzVyPUKzMlUyQDJizszN	NEjZcJNUSU6JRWK=
UACC-62	NVzjNnloT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3vzWmlEPTB;MkOuOVg{OyEQvF2=	MlrkV2FPT0WU
D-247MG	MlmwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mm\QTWM2OD1{Mz63PVM6KM7:TR?=	MWPTRW5ITVJ?
COLO-741	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4jkVmlEPTB;MkOuPVU3PSEQvF2=	MUDTRW5ITVJ?
ES3	MnLUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NIjLVphKSzVyPUK0MlAxOjNizszN	M2LN[XNCVkeHUh?=
LNCaP-Clone-FGC	NEjTN\|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUWwenM2UUN3ME2yOE4xOjFzIN88US=>	NVGydWtYW0GQR1XS
SW1710	NHThflNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Ml62TWM2OD1{ND6xOVA3KM7:TR?=	M1TYfnNCVkeHUh?=
LU-99A	MmTrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXrJR\|UxRTJ2LkG4OFEh\|ryP	MWrTRW5ITVJ?
HOP-92	NIHHNotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFKxSZVKSzVyPUK0MlczPSEQvF2=	MnHRV2FPT0WU
LS-123	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1TT[GlEPTB;MkSuPVYyPCEQvF2=	MojnV2FPT0WU
T84	NFXSWZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVHJR\|UxRTJ2Lkm3OlUh\|ryP	NXvveGhkW0GQR1XS
HCT-116	NGLzdJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGfncZlKSzVyPUK1MlQyQDZizszN	NVzEcGQ6W0GQR1XS
M14	NUT5c5g6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mlj4TWM2OD1{NT60OFQ4KM7:TR?=	MXXTRW5ITVJ?
OCUB-M	MlLTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUfJR\|UxRTJ3LkS0OVYh\|ryP	MXPTRW5ITVJ?
MKN45	M3j5eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWXicXh5UUN3ME2yOU43OzF3IN88US=>	NGOzd4dUSU6JRWK=
LCLC-97TM1	NFnHcGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFPiOYFKSzVyPUK1MlczQDVizszN	NVrvR204W0GQR1XS
RVH-421	NHnrNoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3HJTWlEPTB;MkWuPFE3OSEQvF2=	Mn35V2FPT0WU
NKS-81-FD	MoLiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkDRTWM2OD1{NT65NFIyKM7:TR?=	M3HrcXNCVkeHUh?=
NCI-H596	NYXMTlVTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4\ySmlEPTB;Mk[uNFQ5PyEQvF2=	MmnlV2FPT0WU
GB-1	NWPNdml3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Moq5TWM2OD1{Nj6xPFc6KM7:TR?=	MmXPV2FPT0WU
ZR-75-30	NYLXWIY6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NIL0S\|dKSzVyPUK2MlIzQTdizszN	MX3TRW5ITVJ?
U-2-OS	NF7MfWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVfNTlNXUUN3ME2yOk4{PzV5IN88US=>	MVLTRW5ITVJ?
HuP-T3	Ml;LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHXuS4VKSzVyPUK2MlYyODJizszN	Moe2V2FPT0WU
MOLT-16	MmTJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MULJR\|UxRTJ4Lk[xOlYh\|ryP	NYS1RpR{W0GQR1XS
U-87-MG	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVuxWYFFUUN3ME2yOk44PDN6IN88US=>	MoG5V2FPT0WU
8505C	MoPTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1roZmlEPTB;Mk[uPVEzPiEQvF2=	NHm1SIFUSU6JRWK=
SK-MEL-3	M1zZSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{PvbmlEPTB;Mk[uPVgzQCEQvF2=	NYHZXm9uW0GQR1XS
COLO-824	Mnm4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mn\LTWM2OD1{Nz6yNVk2KM7:TR?=	NWfodYlNW0GQR1XS
EW-1	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVjGU4F5UUN3ME2yO{4{PTV2IN88US=>	NIP4bVZUSU6JRWK=
UACC-257	M3r3Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NH3tNItKSzVyPUK3MlM5ODRizszN	M4TTUXNCVkeHUh?=
Hs-578-T	NUTYNmpuT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MkLjTWM2OD1{Nz61Nlk6KM7:TR?=	MULTRW5ITVJ?
UACC-893	NILvUpNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUnTeYVJUUN3ME2yO{43PjNzIN88US=>	M3nPSnNCVkeHUh?=
MHH-NB-11	Mn7HS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXr1OZVKUUN3ME2yO{45ODB5IN88US=>	MWnTRW5ITVJ?
KYSE-410	M2D1Smdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NH\JUYRKSzVyPUK4MlI4PzlizszN	NV7HOoFwW0GQR1XS
SF126	M1\jOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnPWTWM2OD1{OD63OFM2KM7:TR?=	NEDvO4VUSU6JRWK=
HT-144	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NG\hcmVKSzVyPUK5MlM{PjJizszN	MnnLV2FPT0WU
SW1573	NFL5ZoVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MX3JR\|UxRTJ7LkO1NFkh\|ryP	M1iyVXNCVkeHUh?=
SW620	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlXYTWM2OD1{OT6zOlQyKM7:TR?=	NETJXnVUSU6JRWK=
SCH	MmL0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmjwTWM2OD1{OT64PFMyKM7:TR?=	MUDTRW5ITVJ?
EW-22	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmPxTWM2OD1\|MD6xPVY6KM7:TR?=	NYDDWo5bW0GQR1XS
H4	MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXe3em9MUUN3ME2zNE41PjV2IN88US=>	MkDOV2FPT0WU
CAS-1	MmrrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NIfLcYRKSzVyPUOwMlc5PTlizszN	NVzzb2R[W0GQR1XS
MG-63	NGPHUJVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWH3SpY2UUN3ME2zNE45PDd6IN88US=>	MWLTRW5ITVJ?
MDA-MB-415	NWPkdoMxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NVvCWoZFUUN3ME2zNU4yPzV\|IN88US=>	M1nxVHNCVkeHUh?=
NCI-H1395	MnnVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1OyZ2lEPTB;M{GuNlMzQCEQvF2=	MlG2V2FPT0WU
Ca-Ski	M2rSZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFP2WHZKSzVyPUOxMlMyPzdizszN	Ml6zV2FPT0WU
BxPC-3	NF3kfllIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnjnTWM2OD1\|MT6zO\|I6KM7:TR?=	MmPSV2FPT0WU
A3-KAW	NIHUdIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NH7WO\|JKSzVyPUOxMlQ1PzFizszN	NFHJUItUSU6JRWK=
T-24	MkTyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{fpeWlEPTB;M{GuO\|M3OiEQvF2=	MkLNV2FPT0WU
NCI-H2029	NVLEXVNYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2PlcWlEPTB;M{GuO\|c3PSEQvF2=	NHnnV5NUSU6JRWK=
YAPC	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NEXUXmNKSzVyPUOyMlA1ODdizszN	NFnDdIVUSU6JRWK=
SK-MEL-2	NFLpOXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3vMRmlEPTB;M{KuNFUzKM7:TR?=	MorrV2FPT0WU
LS-513	MorsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXTJR\|UxRTN{LkGxPFch\|ryP	Mlu3V2FPT0WU
AsPC-1	M1PmTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXrJR\|UxRTN{LkO2NFUh\|ryP	M2jQeXNCVkeHUh?=
KYSE-150	MlWzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWDJR\|UxRTN{LkO3O\|Mh\|ryP	NF74[3dUSU6JRWK=
NCI-H520	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVXJR\|UxRTN{LkS0PFIh\|ryP	Mom2V2FPT0WU
JEG-3	NVOwVIRKT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NVvtcJJ1UUN3ME2zN{4xQTdzIN88US=>	NF\VWXZUSU6JRWK=
GMS-10	M1m5fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NF[xdIJKSzVyPUOzMlMxODRizszN	MU\TRW5ITVJ?
HT-1080	NYrRZoN[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MlLvTWM2OD1\|Mz6zPUDPxE1?	MlO4V2FPT0WU
NCI-H1651	NEGwRY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXS2NIlNUUN3ME2zN{4{QTZizszN	MkfaV2FPT0WU
NCI-H2122	M37CSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnGzTWM2OD1\|Mz61OVc1KM7:TR?=	NFPJfWRUSU6JRWK=
ES5	NYjaV4tKT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXTPe4dzUUN3ME2zN{44Ojl{IN88US=>	M2jNNnNCVkeHUh?=
8305C	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlnkTWM2OD1\|Mz65PVM4KM7:TR?=	NGLmfZhUSU6JRWK=
KM12	NHryUIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHnKRVRKSzVyPUO0MlA1PzhizszN	NFTneHJUSU6JRWK=
HCT-15	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkjGTWM2OD1\|ND6xNlch\|ryP	NGjQbXBUSU6JRWK=
OVCAR-5	Mk[2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NYW4T5h{UUN3ME2zOE4zOTh{IN88US=>	NV3QNmU5W0GQR1XS
NCI-H2291	MkPUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVXwWm5jUUN3ME2zOE4zPDd{IN88US=>	NF3zemRUSU6JRWK=
CP50-MEL-B	M165PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MoPNTWM2OD1\|ND62OVkzKM7:TR?=	M{myUXNCVkeHUh?=
C-33-A	NY\DVnFZT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYrJR\|UxRTN2Lk[4OVch\|ryP	MUPTRW5ITVJ?
NCI-H2452	M2PiNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MVnJR\|UxRTN2Lke4PFIh\|ryP	MmrVV2FPT0WU
MDA-MB-157	MkfiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGnONoZKSzVyPUO0MlgyQTNizszN	MXTTRW5ITVJ?
LN-405	M1TyfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4rNcmlEPTB;M{WuOFMxQCEQvF2=	NHm0VVhUSU6JRWK=
MDA-MB-231	M2rWZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnTYTWM2OD1\|NT61NFU1KM7:TR?=	M2XNZXNCVkeHUh?=
EW-24	MknKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkfKTWM2OD1\|NT62N\|M2KM7:TR?=	MWHTRW5ITVJ?
MKN28	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYHH[mJLUUN3ME2zOU45OjN4IN88US=>	M4rHRnNCVkeHUh?=
KINGS-1	NIjv[4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHHDToRKSzVyPUO1Mlg1OzRizszN	NFe1[G1USU6JRWK=
LC-2-ad	M3;M[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlH2TWM2OD1\|Nj62PVkh\|ryP	MkfCV2FPT0WU
IGR-1	NGi0TXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUP4b3VuUUN3ME2zOk44ODd3IN88US=>	M2DLSHNCVkeHUh?=
SW626	NVm4R\|BGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NEXVe\|BKSzVyPUO3MlA1OTdizszN	NXHFT25sW0GQR1XS
ONS-76	M4qzNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnfFTWM2OD1\|Nz6xN\|A6KM7:TR?=	MmrYV2FPT0WU
T98G	Mlm4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGO1R4lKSzVyPUO3Mlg3OzVizszN	NG[wUmRUSU6JRWK=
NB14	NWXiVmZsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVzJR\|UxRTN6LkS1OFQh\|ryP	MXPTRW5ITVJ?
D-423MG	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NV3mRVNUUUN3ME2zPE41QDZ7IN88US=>	NEPEXHNUSU6JRWK=
NCI-H510A	M3\mfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NEnubo9KSzVyPUO4MlY1PTFizszN	M3zJZ3NCVkeHUh?=
NMC-G1	NE\yWWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXLzfpg2UUN3ME2zPE44OjJ{IN88US=>	NVzwfFIyW0GQR1XS
SW948	NE\icVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3nuZ2lEPTB;M{iuPFk1QSEQvF2=	NWW2OlVzW0GQR1XS
MFM-223	NYDlRZVrT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NU\STFd3UUN3ME2zPE46PDNzIN88US=>	NFXjb5VUSU6JRWK=
PAN1	MnPMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NIO4c\|JKSzVyPUO4Mlk6OTlizszN	NH[3ZXRUSU6JRWK=
MZ7-mel	NIe1W5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3fqfGlEPTB;M{muNVE6QSEQvF2=	M{LOWHNCVkeHUh?=
COLO-679	M2TnTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3r5S2lEPTB;M{muPVcxQCEQvF2=	MkHuV2FPT0WU
SW872	M4XXOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NH\oelFKSzVyPUSwMlIxOzFizszN	MXHTRW5ITVJ?
HT-1197	MnfNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NYfEOWU{UUN3ME20NE4zQDZ7IN88US=>	M2jifnNCVkeHUh?=
ES6	MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NIK4bFVKSzVyPUSwMlQ2PTJizszN	M2rWbnNCVkeHUh?=
SNU-387	MkLGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mk\vTWM2OD12MD64NlM5KM7:TR?=	NFLDToZUSU6JRWK=
T47D	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnjSTWM2OD12MT6wNVkzKM7:TR?=	NHS0OXJUSU6JRWK=
G-402	NEfRTW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHq5fpBKSzVyPUSxMlA5ODlizszN	MlHZV2FPT0WU
MZ1-PC	NIe3e3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{XGd2lEPTB;NEGuPFEh\|ryP	M4PYVnNCVkeHUh?=
SW1417	NWLBd2RDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MUnJR\|UxRTR{LkOwN{DPxE1?	Mon5V2FPT0WU
RERF-LC-MS	M1G4N2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NIOyboRKSzVyPUSyMlUxQDdizszN	M3jlbnNCVkeHUh?=
SF539	M{nCcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4\PeWlEPTB;NEKuOVUzQSEQvF2=	MnHXV2FPT0WU
ESS-1	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHzjcI1KSzVyPUSzMlU2PThizszN	MUDTRW5ITVJ?
RO82-W-1	M4fmOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWO2WGVyUUN3ME20N{43OTV\|IN88US=>	MkPXV2FPT0WU
S-117	NXPhfGVVT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGDjZnNKSzVyPUSzMlY6PThizszN	NYH3cmVmW0GQR1XS
SW756	MkP2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVu3UVg{UUN3ME20N{45OjR{IN88US=>	NFv0elVUSU6JRWK=

研究领域